UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended February 28,November 30, 2018
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Commission File Number:333-174705000-55546
CLS HOLDINGS USA, INC.
(Exact name of registrant as specified in its charter)
Nevada | 45-1352286 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
11767 South Dixie Highway, Suite115, Miami, Florida 33156
(Address of principal executive offices) (Zip Code)
(888) 438-9132
Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
(Check One):
Large Accelerated filer ☐ | Accelerated filer ☐ |
Non-accelerated filer ☐ (Do not check if a smaller reporting company) | Smaller reporting company ☒ |
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
State the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: 48,482,972125,814,095 shares of $0.0001 par value common stock outstanding as of April 2, 2018.
CLS HOLDINGS USA, INC.
FORM 10-Q
Quarterly Period Ended February 28,November 30, 2018
Page | ||
3 | ||
PART I. FINANCIAL INFORMATION | ||
Item 1. | 4 | |
4 | ||
5 | ||
6 | ||
7 | ||
Item 2. | 36 | |
Item 3. | 52 | |
Item 4. | 52 | |
PART II. OTHER INFORMATION | ||
Item 1. | 53 | |
Item 1A. | 53 | |
Item 2. | 53 | |
Item 3. | 53 | |
Item 4. | 53 | |
Item 5. | 53 | |
Item 6. | 54 | |
55 |
EXPLANATORY NOTE
Unless otherwise noted, references in this registration statement to “CLS Holdings USA, Inc.,” the “Company,” “we,” “our” or “us” means CLS Holdings USA, Inc. and its subsidiaries.
This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. These forward-looking statements include, but are not limited to, statements relating to our ability to finance our planned operations and proposed acquisitions, market acceptance of our services and product offerings, our ability to attractcommence and retain key personnel,complete expansion plans and buildouts on schedule and on budget, and our ability to protect and commercialize our intellectual property. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology.
These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.
We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.
AVAILABLE INFORMATION
We file annual, quarterly and special reports and other information with the Securities and Exchange Commission (“SEC”) that can be inspected and copied at the public reference facility maintained by the SEC at 100 F Street, N.E., Room 1580, Washington, D.C. 20549-0405. Information regarding the public reference facilities may be obtained from the SEC by telephoning 1-800-SEC-0330. The Company’s filings are also available through the SEC’s Electronic Data Gathering Analysis and Retrieval System, which is publicly availableknown as EDGAR, through the SEC’s website (www.sec.gov). Copies of such materials may also be obtained by mail from the public reference section of the SEC at 100 F Street, N.E., Room 1580, Washington, D.C. 20549-0405 at prescribed rates.
CLS HOLDINGS USA, INC.
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
ASSETS | (unaudited) | |||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 22,733 | $ | 78,310 | ||||
Prepaid expenses | 12,598 | 1,410 | ||||||
Other current assets | 23,431 | - | ||||||
Total current assets | 58,762 | 79,720 | ||||||
Investment | 2,050,000 | - | ||||||
Security deposit | - | 50,000 | ||||||
Property, plant and equipment, net of accumulated depreciation of $2,453 and $1,784 | 221 | 890 | ||||||
Intangible assets, net of accumulated amortization of $1,152 and $828 | 1,006 | 1,330 | ||||||
Total assets | $ | 2,109,989 | $ | 131,940 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable and accrued liabilities | $ | 671,807 | $ | 581,765 | ||||
Accrued compensation, related party | 108,834 | 53,750 | ||||||
Notes Payable | 410,000 | - | ||||||
Due to related party | 17,930 | 17,930 | ||||||
Accrued interest | 9,602 | 20,171 | ||||||
Accrued interest, related party | 193,988 | 106,022 | ||||||
Notes payable, related parties | 152,174 | 699,208 | ||||||
Convertible notes payable, net of discount of $826,775 and $57,644 | 141,225 | 252,356 | ||||||
Convertible notes payable, related party, net of discount of $98,382 and $0 | 114,803 | - | ||||||
Derivative liability | 974,175 | 95,276 | ||||||
Total current liabilities | 2,794,538 | 1,826,478 | ||||||
Noncurrent liabilities | ||||||||
Convertible notes payable, related parties, net of discount of $623,847 and $0 | 615,574 | 192,000 | ||||||
Total Liabilities | 3,410,112 | 2,018,478 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholder’s equity | ||||||||
Common stock, $0.0001 par value; 250,000,000 shares authorized; 43,186,944 and 32,852,944 shares issued and outstanding at February 28, 2018 and May 31, 2017, respectively | 4,319 | 3,286 | ||||||
Preferred stock, $0.001 par value; 20,000,000 shares authorized; no shares issued | - | - | ||||||
Additional paid-in capital | 13,224,661 | 7,032,836 | ||||||
Common stock subscriptions receivable | (69,102 | ) | - | |||||
Common stock subscribed | 123,950 | 68,950 | ||||||
Accumulated deficit | (14,583,951 | ) | (8,991,610 | ) | ||||
Total stockholder’s equity (deficit) | (1,300,123 | ) | (1,886,538 | ) | ||||
Total liabilities and stockholders’ equity (deficit) | $ | 2,109,989 | $ | 131,940 |
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 4,872,048 | $ | 52,964 | ||||
Accounts Receivable | 78,419 | - | ||||||
Inventory | 870,984 | - | ||||||
Prepaid expenses and other current assets | 176,944 | 1,410 | ||||||
Total current assets | 5,998,395 | 54,374 | ||||||
Investment | - | 2,050,000 | ||||||
Note receivable | 5,000,000 | - | ||||||
Interest receivable | 24,658 | - | ||||||
Property, plant and equipment, net of accumulated depreciation of $76,167 and $2,674 | 892,070 | - | ||||||
Intangible assets, net of accumulated amortization of $54,169 and $828 | 1,587,913 | 898 | ||||||
Goodwill | 25,742,899 | - | ||||||
Other assets | 160,450 | - | ||||||
Total assets | $ | 39,406,385 | $ | 2,105,272 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable and accrued liabilities | $ | 1,509,617 | $ | 826,621 | ||||
Accrued compensation, related party | 53,750 | 120,417 | ||||||
Due to related party | 17,930 | 17,930 | ||||||
Accrued interest | 164,852 | 24,748 | ||||||
Accrued interest, related party | 5,573 | 5,143 | ||||||
Notes payable, net of discount of $132,967 and $0 | 3,867,033 | 310,000 | ||||||
Notes payable, related parties | 48,874 | 75,137 | ||||||
Convertible notes payable, net of discount of $603,187 and $57,644 | 396,813 | 43,401 | ||||||
Contingent liability | 678,111 | - | ||||||
Derivative liability | - | 1,265,751 | ||||||
Total current liabilities | 6,742,553 | 2,689,148 | ||||||
Noncurrent liabilities | ||||||||
Accrued interest, long-term | - | - | ||||||
Convertible notes payable - Long Term, net of discount of $4,740,688 and $0 | 1,116,312 | 41,072 | ||||||
Convertible notes payable, related parties, net of discount of $0 and $0 | - | 2,832 | ||||||
Total Liabilities | 7,858,865 | 2,733,052 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholder's equity | ||||||||
Preferred stock, $0.001 par value; 20,000,000 shares authorized; no shares issued | - | - | ||||||
Common stock, $0.0001 par value; 250,000,000 shares authorized; 91,150,451 and 50,128,972 shares issued and outstanding at November 30, 2018 and May 31, 2018, respectively | 9,116 | 5,013 | ||||||
Additional paid-in capital | 69,211,175 | 17,628,717 | ||||||
Common stock subscribed | 252,506 | 307,584 | ||||||
Accumulated deficit | (37,925,277 | ) | (18,569,094 | ) | ||||
Total stockholder's equity (deficit) | 31,547,520 | (627,780 | ) | |||||
Total liabilities and stockholders' equity (deficit) | $ | 39,406,385 | $ | 2,105,272 |
See accompanying notes to these financial statements.
CLS HOLDINGS USA, INC.
(Unaudited)
For the Three | For the Thee | For the Nine | For the Nine | |||||||||||||
Months Ended | Months Ended | Months Ended | Months Ended | |||||||||||||
February 28, 2018 | February 28, 2017 | February 28, 2018 | February 28, 2017 | |||||||||||||
Revenue | $ | - | $ | - | $ | - | $ | - | ||||||||
Cost of goods sold | - | - | - | - | ||||||||||||
Gross margin | - | - | - | - | ||||||||||||
Selling, general and administrative expenses | 838,047 | 144,204 | 1,136,468 | 482,071 | ||||||||||||
Professional fees | 376,924 | 99,867 | 695,086 | 603,098 | ||||||||||||
Total operating expenses | 1,214,971 | 244,071 | 1,831,554 | 1,085,169 | ||||||||||||
Operating loss | (1,214,971 | ) | (244,071 | ) | (1,831,554 | ) | (1,085,169 | ) | ||||||||
Other (income) expense: | ||||||||||||||||
Interest expense | 1,434,314 | 381,149 | 2,316,145 | 1,395,511 | ||||||||||||
Gain on settlement of debt | - | - | (3,480 | ) | - | |||||||||||
Loss on modification of debt | - | - | 29,145 | 33,334 | ||||||||||||
Loss on note exchange | - | - | 404,082 | - | ||||||||||||
Loss on extinguishment of debt | - | - | 989,032 | - | ||||||||||||
Change in fair value of derivative | (148,227 | ) | (244,848 | ) | 25,863 | (393,114 | ) | |||||||||
Total other expense | 1,286,087 | 136,301 | 3,760,787 | 1,035,731 | ||||||||||||
Income (Loss) before income taxes | (2,501,058 | ) | (380,372 | ) | (5,592,341 | ) | (2,120,900 | ) | ||||||||
Income tax expense | - | - | - | - | ||||||||||||
Net income (loss) | $ | (2,501,058 | ) | $ | (380,372 | ) | $ | (5,592,341 | ) | $ | (2,120,900 | ) | ||||
Net income (loss) per share - basic | $ | (0.06 | ) | $ | (0.02 | ) | $ | (0.16 | ) | $ | (0.10 | ) | ||||
Net income (loss) per share - diluted | $ | (0.06 | ) | $ | (0.02 | ) | $ | (0.16 | ) | $ | (0.10 | ) | ||||
Weighted average shares outstanding - basic | 39,126,944 | 20,465,360 | 35,654,299 | 20,388,033 | ||||||||||||
Weighted average shares outstanding - diluted | 39,126,944 | 20,465,360 | 35,654,299 | 20,388,033 |
For the Three | For the Three | For the Six | For the Six | |||||||||||||
Months Ended | Months Ended | Months Ended | Months Ended | |||||||||||||
November 30, 2018 | November 30, 2017 | November 30, 2018 | November 30, 2017 | |||||||||||||
Revenue | $ | 1,976,910 | $ | - | $ | 3,156,263 | $ | - | ||||||||
Cost of goods sold | 1,046,667 | - | 1,806,611 | - | ||||||||||||
Gross margin | 930,243 | - | 1,349,652 | - | ||||||||||||
Selling, general and administrative expenses | 2,977,036 | 257,379 | 18,369,166 | 616,583 | ||||||||||||
Total operating expenses | 2,977,036 | 257,379 | 18,369,166 | 616,583 | ||||||||||||
Operating loss | (2,046,793 | ) | (257,379 | ) | (17,019,514 | ) | (616,583 | ) | ||||||||
Other (income) expense: | ||||||||||||||||
Interest expense, net | 652,450 | 806,965 | 2,336,669 | 881,831 | ||||||||||||
Gain on settlement of debt | - | - | - | (3,480 | ) | |||||||||||
Loss on modification of debt | - | - | - | 29,145 | ||||||||||||
Loss on note exchange | - | 404,082 | - | 404,082 | ||||||||||||
Loss on extinguishment of debt | - | 989,032 | - | 989,032 | ||||||||||||
Change in fair value of derivative | - | 68,140 | - | 174,090 | ||||||||||||
Total other expense | 652,450 | 2,268,219 | 2,336,669 | 2,474,700 | ||||||||||||
Income (Loss) before income taxes | (2,699,243 | ) | (2,525,598 | ) | (19,356,183 | ) | (3,091,283 | ) | ||||||||
Income tax expense | - | - | - | - | ||||||||||||
Net income (loss) | $ | (2,699,243 | ) | $ | (2,525,598 | ) | $ | (19,356,183 | ) | $ | (3,091,283 | ) | ||||
Net income (loss) per share - basic | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.24 | ) | $ | (0.09 | ) | ||||
Net income (loss) per share - diluted | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.24 | ) | $ | (0.09 | ) | ||||
Weighted average shares outstanding - basic | 90,338,339 | 35,039,032 | 80,765,385 | 33,946,441 | ||||||||||||
Weighted average shares outstanding - diluted | 90,338,339 | 35,039,032 | 80,765,385 | 33,946,441 |
See accompanying notes to these financial statements.
CLS HOLDINGS USA, INC.
(Unaudited)
For the Nine | For the Nine | |||||||
Months Ended | Months Ended | |||||||
February 28, 2017 | February 28, 2016 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net income (loss) | $ | (5,592,341 | ) | $ | (2,120,900 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Imputed interest | 804 | 804 | ||||||
Change in fair value of derivative | 25,863 | (393,114 | ) | |||||
Share-based compensation | 55,000 | - | ||||||
Warrants issued to placement agent | 610,414 | - | ||||||
Loss on modification of debt | 29,145 | 33,334 | ||||||
(Gain) loss on note exchange | 404,082 | - | ||||||
Loss on extinguishment of debt | 989,032 | - | ||||||
Gain on settlement of debt | (3,480 | ) | - | |||||
Amortization of debt discounts | 1,391,110 | 1,197,998 | ||||||
Amortization of deferred financing costs | 22,569 | - | ||||||
Depreciation and amortization expense | 993 | 993 | ||||||
Changes in assets and liabilities: | ||||||||
Other assets | 50,000 | - | ||||||
Prepaid expenses | (11,188 | ) | (16,049 | ) | ||||
Other current assets | (46,000 | ) | - | |||||
Accounts payable and accrued expenses | 937,895 | 137,699 | ||||||
Accrued compensation | 167,584 | 112,500 | ||||||
Due to related parties | - | - | ||||||
Accrued interest, related party | 87,966 | 131,042 | ||||||
Deferred rent | (49,565 | ) | - | |||||
Accrued interest | 21,045 | 16,402 | ||||||
Net cash used in operating activities | (909,072 | ) | (899,291 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Payment for investment in Oasis LLCs | (2,050,000 | ) | - | |||||
Payment for construction in progress | - | (35,013 | ) | |||||
Net cash used in investing activities | (2,050,000 | ) | (35,013 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Proceeds from related party convertible notes payable | 601,070 | 150,000 | ||||||
Proceeds from related party notes payable | - | 838,000 | ||||||
Proceeds from convertible notes | 880,000 | - | ||||||
Proceeds from notes payable | 410,000 | - | ||||||
Principal payments on related party notes payable | - | (61,000 | ) | |||||
Repayments of convertible notes payable | - | (75,000 | ) | |||||
Proceeds from sale of equity | 1,012,425 | - | ||||||
Net cash provided by financing activities | 2,903,495 | 852,000 | ||||||
Net increase in cash and cash equivalents | (55,577 | ) | (82,304 | ) | ||||
Cash and cash equivalents at beginning of period | 78,310 | 88,244 | ||||||
Cash and cash equivalents at end of period | $ | 22,733 | $ | 5,940 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
Interest paid | $ | - | $ | - | ||||
Income taxes paid | $ | - | $ | - | ||||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
Convertible note issued for unpaid accrued salary | $ | 112,500 | $ | 250,000 | ||||
Related party notes payable reclassified as related party convertible notes payable | $ | 1,116,856 | $ | 222,750 | ||||
Beneficial conversion feature on convertible notes payable | $ | 1,681,946 | $ | - | ||||
Note payable exchanged for common stock | $ | 936,478 | $ | 518,720 | ||||
Shares issued for settlement of accounts payable | $ | 6,000 | $ | - | ||||
Extinguishment of debt | $ | $ | 254,114 | |||||
Discount on convertible notes payable due to derivative | $ | 1,321,862 | $ | - | ||||
Common stock issued for conversion of notes payable | $ | - | $ | 222,657 |
For the Six | For the Six | |||||||
Months Ended | Months Ended | |||||||
November 30, 2018 | November 30, 2017 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net income (loss) | $ | (19,356,183 | ) | $ | (3,091,283 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Imputed interest | 539 | 539 | ||||||
Change in fair value of derivative | - | 174,090 | ||||||
Warrants issued to placement agent | 2,908,673 | - | ||||||
Warrants and Special Warrants issued to penalty | 8,084,522 | - | ||||||
Non-cash offering costs of equity financing | 403,588 | - | ||||||
Fair value of shares vested by officers | 230,888 | - | ||||||
Fair value of shares issued to consultants | 490,000 | - | ||||||
Fair value of shares issued in settlement | 47,500 | - | ||||||
Loss on modification of debt | - | 29,145 | ||||||
(Gain) loss on note exchange | - | 404,082 | ||||||
Loss on extinguishment of debt | - | 989,032 | ||||||
Gain on settlement of Account Payable | - | (3,480 | ) | |||||
Expense from derivative triggering event | 12,659 | - | ||||||
Amortization of debt discounts | 2,144,328 | 572,856 | ||||||
Amortization of deferred financing costs | 3,119 | |||||||
Depreciation and amortization expense | 128,531 | 662 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable | (42,982 | ) | - | |||||
Interest receivable | (24,658 | ) | - | |||||
Inventory | (465,031 | ) | - | |||||
Prepaid expenses | (72,295 | ) | (25,000 | ) | ||||
Other assets | - | 50,000 | ||||||
Other current assets | - | (39,500 | ) | |||||
Accounts payable and accrued expenses | (376,353 | ) | 334,018 | |||||
Accrued compensation | (16,667 | ) | 112,500 | |||||
Due to related parties | (50,000 | ) | - | |||||
Accrued interest, related party | 5,211 | 52,281 | ||||||
Accrued interest | 188,736 | 12,189 | ||||||
Deferred rent liability | 1,667 | - | ||||||
Net cash used in operating activities | (5,757,327 | ) | (424,750 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Payments to purchase property, plant and equipment | (35,095 | ) | - | |||||
Payments to acquire note receivable | (5,000,000 | ) | - | |||||
Payment for investment in Alternative Solutions, net of cash received of $14,612 | (5,982,710 | ) | - | |||||
Net cash used in investing activities | (11,017,805 | ) | - | |||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Proceeds from related party convertible notes payable | - | - | ||||||
Proceeds from related party notes payable | 158,615 | 275,629 | ||||||
Proceeds from convertible notes payable | 6,357,000 | 330,000 | ||||||
Principal payments on notes payable | (310,000 | ) | - | |||||
Principal payments on related party notes payable | (109,877 | ) | - | |||||
Principal payments on convertible notes payable | (37,500 | ) | - | |||||
Proceeds from sale of equity | 15,535,978 | - | ||||||
Net cash provided by financing activities | 21,594,216 | 605,629 | ||||||
Net increase in cash and cash equivalents | 4,819,084 | 180,879 | ||||||
Cash and cash equivalents at beginning of period | 52,964 | 78,310 | ||||||
Cash and cash equivalents at end of period | $ | 4,872,048 | $ | 259,189 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
Interest paid | $ | 8,964 | $ | - | ||||
Income taxes paid | $ | - | $ | - | ||||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
Convertible note issued for unpaid accrued salary | $ | 75,000 | $ | 75,000 | ||||
Related party notes payable reclassified as related party convertible notes payable | $ | - | $ | 873,996 | ||||
Beneficial conversion feature on convertible notes | $ | 6,047,322 | $ | 508,988 | ||||
Note payable exchanged for common stock | $ | 1,039,663 | $ | 936,478 | ||||
Shares issued for settlement of accounts payable | $ | - | $ | 6,000 | ||||
Discount on convertible notes payable due to derivative | - | $ | 802,381 | |||||
Charge to paid-in capital for par value of shares issued in cashless exercise of warrants | $ | 3,362 | $ | - | ||||
Reclassify derivative liability to paid-in capital upon adoption of ASU 2017-11 | $ | 1,265,751 | $ | - | ||||
Shares issued for services from stock payable | $ | 25,313 | $ | - |
See accompanying notes to these financial statements.
CLS HOLDINGS USA, INC.
November 30, 2018
(Unaudited)
Note 1 – Nature of Business and Significant Accounting Policies
Basis of Presentation
These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in US dollars.
Principals of Consolidation
The accompanying consolidated financial statements include the accounts of CLS Holdings USA, Inc., and its wholly owned operating subsidiaries, CLS Nevada, Inc., (“CLS Nevada”), CLS Labs, Inc. (“CLS Labs”), CLS Labs Colorado, Inc. (“CLS Colorado”), and Alternative Solutions, LLC (“Alternative Solutions”). Alternative Solutions is sole owner of the following three entities (collectively, the “Oasis LLCs”): Serenity Wellness Center, LLC (“Serenity Wellness Center”); Serenity Wellness Products, LLC (“Serenity Wellness Products”); and Serenity Wellness Growers, LLC (“Serenity Wellness Growers”). All material intercompany transactions have been eliminated upon consolidation of these entities.
Nature of Business
CLS Holdings USA, Inc. (the “Company”) was originally incorporated as Adelt Design, Inc. (“Adelt”) on March 31, 2011 to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced.
On November 12, 2014, CLS Labs, Inc. (“CLS Labs”) acquired 10,000,000 shares, or 55.6%, of the outstanding shares of common stock of Adelt from its founder, Larry Adelt. On that date, Jeffrey Binder, the Chairman, President and Chief Executive Officer of CLS Labs, was appointed Chairman, President and Chief Executive Officer of the Company. On November 20, 2014, Adelt adopted amended and restated articles of incorporation, thereby changing its name to CLS Holdings USA, Inc. Effective December 10, 2014, the Company effected a reverse stock split of its issued and outstanding common stock at a ratio of 1-for-0.625 (the “Reverse Split”), wherein 0.625 shares of the Company’s common stock were issued in exchange for each share of common stock issued and outstanding. As a result, 6,250,000 shares of the Company’s common stock were issued to CLS Labs in exchange for the 10,000,000 shares that it owned by virtue of the above-referenced purchase from Larry Adelt.
On April 29, 2015, the Company, CLS Labs and CLS Merger Inc., a Nevada corporation and wholly owned subsidiary of CLS Holdings (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) and completed a merger, whereby CLS Merger Inc. merged with and into CLS Labs, with CLS Labs remaining as the surviving entity (the “Merger”). Upon the consummation of the Merger, the shares of the common stock of CLS Holdings owned by CLS Labs were extinguished and the former stockholders of CLS Labs were issued an aggregate of 15,000,000 (post Reverse Split) shares of common stock in CLS Holdings in exchange for their shares of common stock in CLS Labs. As a result of the Merger, the Company acquired the business of CLS Labs and abandoned its previous business.
The Company has been issued a U.S. patent allowance with respect to its proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes (“e-cigarettes”), and used for a variety of pharmaceutical and other purposes. Internal testing of this extraction method and conversion process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace. The Company has not commercialized its proprietary process or otherwise earned any revenues.revenues from it. The Company plans to generate revenues through licensing, fee-for-service and joint venture arrangements related to its proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into saleable concentrates.
On December 4, 2017, the Company and Alternative Solutions, LLC (“Alternative Solutions”) entered into a Membership Interest Purchase Agreement (the “Acquisition Agreement”), as amended, for the Company to acquire the Oasis LLCs from Alternative Solutions. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions.
Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (the “Oasis Note”), and 22,058,823 shares of its common stock (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of its recent Canadian private securities offering to fund the cash portion of the Closing Consideration. The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018. The Company has adopted a fiscal year end of May 31st.
On October 31, 2018, the Company, CLS Massachusetts, Inc., a Massachusetts corporation and a wholly-owned subsidiary of Presentation
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents. The Company had cash and cash equivalents of $22,733$4,872,048 and $78,310$52,964 as of February 28,November 30, 2018 and May 31, 2017,2018, respectively.
Allowance for Doubtful Accounts
The Company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products. The Company evaluates the collectability of its accounts receivable considering a combination of factors. In circumstances where it is aware of a specific customer’s inability to meet its financial obligations to it, the Company records a specific reserve for bad debts against amounts due in order to reduce the net recognized receivable to the amount it reasonably believe will be collected. For all other customers, the Company recognizes reserves for bad debts based on past write-off experience and the length of time the receivables are past due. The Company had no bad debts expense during the three and six months ended November 30, 2018 and 2017.
Segment Reporting
Under FASB ASC 280-10-50, the Company operates two business segments: Cannabis Dispensary Segment, and Cannabis Production Segment, and will evaluate additional segment disclosure requirements as it expands its operations.
Inventory
Inventories are stated at the lower of cost or market. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Market is determined based on net realizable value. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable values. Our cannabis products consists of prepackaged purchased goods ready for resale, and cannabis flower grown in-house under our cultivation license, along with produced edibles and extracts developed under our production license.
Property, Plant and Equipment
Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over the estimated useful lives. Computer equipment is being depreciated over a three-year period.
Concentrations of Credit Risk
The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts.
Advertising and Marketing Costs
All costs associated with advertising and marketing costspromoting products are expensed as incurred.incurred with the exception of the amortization of the cost of two major video productions. A music video and reality/lifestyle video were both produced in 2017. The Company incurred noremaining amount that hasn’t been expensed is listed on the schedule in Note 7. Total recognized advertising and marketing costspromotion expenses were $48,284 and $0 for the three and nine months ended February 28,November 30, 2018 and 2017.
Research and Development
Research and development expenses are charged to operations as incurred. The Company incurred no research and development costs for the three and ninesix months ended February 28,November 30, 2018 and 2017, respectively.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires the establishment of deferred tax assets and liabilities for the temporary differences between the financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided to the extent deferred tax assets may not be recoverable after consideration of the future reversal of deferred tax liabilities, tax planning strategies, and projected future taxable income.
Fair Value of Financial Instruments
Pursuant to Accounting Standards Codification (“ASC”) No. 825 - Financial Instruments, the Company is required to estimate the fair value of all financial instruments included on its balance sheets. The carrying amount of the Company’s cash and cash equivalents, note receivable, notes payable, accounts payable and accrued expenses, none of which is held for trading, approximates their estimated fair values due to the short-term maturities of those financial instruments.
A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.
Level 3 - Significant unobservable inputs that cannot be corroborated by market data.
Derivative Financial Instruments
Derivatives are recorded on the condensed consolidated balance sheet at fair value. The conversion features of the convertible notes are embedded derivatives and are separately valued and accounted for on the consolidated balance sheet with changes in fair value recognized during the period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model the Company uses for determining the fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income (see note 11)16).
Revenue Recognition
Revenue is primarily generated through the Company’s subsidiary, Serenity Wellness Center LLC, d/b/a Oasis Cannabis (“Oasis”). Oasis operates a 24-hour cannabis dispensary that recognizes revenue from productthe sale of medical and recreational cannabis products within the State of Nevada.
Revenue from the sale of cannabis products is recognized by our subsidiary at the point of sale, at which time payment is received. Management estimates an allowance for sales returns.
The Company also recognizes revenue from Serenity Wellness Products LLC and Serenity Wellness Growers LLC, d/b/a City Trees. City Trees recognizes revenue from the sale of the following cannabis products and services to licensed dispensaries within the State of Nevada:
● | Premium organic medical cannabis sold wholesale to licensed retailers |
● | Recreational marijuana cannabis products sold wholesale to distributors and retailers |
● | Extraction products such as oils and waxes derived from in-house cannabis production |
● | Processing and extraction services for licensed medical cannabis cultivators in Nevada |
● | High quality cannabis strains in the form of vegetative cuttings for sale to licensed medical cannabis cultivators in Nevada |
Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue using four basicfrom the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605. Revenue is recognized when the following criteria that must be met before revenue can be recognized:are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the selling priceamount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. Determination
There was no impact on the Company’s financial statements as a result of criteria (3)adopting Topic 606 for the three and (4) is based on management’s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.
Basic and Diluted Loss Per Share
Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully-diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during the period.
The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation.
A net loss causes all outstanding stock options and warrants to be antidilutive. As a result, the basic and dilutive losses per common share are the same for the three and ninesix months ended February 28,November 30, 2018 and 2017.
Commitments and Contingencies
Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims brought to such legal counsel’s attention as well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.
Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed.
Recent Accounting Pronouncements
Accounting standards promulgated by the Financial Accounting Standards Board (“FASB”) are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments.
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230). The update addresses eight specific cash flow issues and is intended to reduce diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update will beis effective for reporting periods beginning after December 15, 2017, including interim periods within the reporting period. Early adoption is permitted. The Company is currently evaluatingdoes not believe the potentialimplementation of this update has had a material impact of the update on its financial statements.
In January 2017, the FASB issued ASU No. 2017-04,
Simplifying the Test for Goodwill Impairment, which simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, current U.S. GAAP requires the performance of procedures to determine the fair value at the impairment testing date of assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, the amendments under this ASU require the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The ASU becomes effective for the Company on January 1, 2020. The amendments in this ASU will be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed.In May 2017, the FASB issued ASU No. 2017-09,
Stock Compensation - Scope of Modification Accounting, which provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The ASU requires that an entity account for the effects of a modification unless the fair value (or calculated value or intrinsic value, if used), vesting conditions and classification (as equity or liability) of the modified award are all the same as for the original award immediately before the modification. The ASUEffective June 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are modified once this standardmet: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is adopted.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.
Adoption of Accounting Standards
In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features.
When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception.
Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.
On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751.
Note 2 – Going Concern
As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $14,583,951$37,925,277 as of February 28,November 30, 2018. FurtherThe Company’s auditors stated in their opinion on the Company’s financial statements for the year ended May 31, 2018 that there was substantial doubt about the Company’s ability to continue as a going concern, and that further losses arewere anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company began generating revenue from operations with the Acquisition of Alternative Solutions, LLC on June 27, 2018 (note 3). Management intends to finance operating costs over the next twelve months with loans, the proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.
Note 3 – Acquisition of Alternative Solutions, LLC
On June 27, 2018, the Company closed on the purchase of all of the membership interests in Alternative Solutions, LLC and its three operating subsidiaries (collectively, the “Oasis LLCs”) from the members of such entities (other than Alternative Solutions). The Oasis LLCs operate a fully integrated cannabis business in Las Vegas, Nevada, including a grow; extraction, conversion and processing facility; and a retail dispensary. The closing occurred pursuant to a Membership Interest Purchase Agreement (the “Acquisition Agreement”) entered into between the Company and Alternative Solutions on December 4, 2017, as amended. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions. The revised structure of the transaction is referenced in the Oasis Note (as defined below), which modified the Acquisition Agreement.
Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (see note 13), (the “Oasis Note”), and 22,058,823 shares of its common stock (see note 15), (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of its recent Canadian private securities offering to fund the cash portion of the Closing Consideration (see note 15). The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018.
The number of Purchase Price Shares was equal to 80% of the offering price of the Company’s common stock in its last equity offering, which price was $0.34 per share. The Oasis Note is secured by a first priority security interest over the membership interests in Alternative Solutions and the Oasis LLCs, as well as by the assets of the Oasis LLCs. The Company also delivered a confession of judgment to a representative of the sellers that will become effective, in general, if the Company defaults default under the Oasis Note.
Oasis currently owes certain amounts to a consultant known as 4Front Advisors, LLC. If the Company makes any payments to this company post-closing, generally speaking, the Company will be entitled to deduct the present value of such payments from the principal amount due under the Oasis Note.
The sellers are also entitled to a $1,000,000 payment from the Company on May 30, 2020 if the Oasis LLCs have maintained an average revenue of $20,000 per day during the 2019 calendar year. The fair value of this contingent consideration was $678,111 as determined by the Company’s outside valuation consultants. This amount is recorded as contingent liability on the Company’s balance sheet at November 30, 2018.
The acquisition date estimated fair value of the consideration transferred totaled $27,975,650, which consisted of the following:
Initial purchase price | $ | 2,050,000 | ||
Cash paid in connection with transaction | 5,995,543 | |||
Note payable | 3,810,820 | |||
Contingent consideration | 678,111 | |||
Common stock | 15,441,176 | |||
Total purchase price | $ | 27,975,650 | ||
Net tangible assets | $ | 595,151 | ||
Intangible assets | 1,637,600 | |||
Goodwill | 25,742,899 | |||
Total purchase price | $ | 27,975,650 |
The above estimated fair value of the intangible assets is based on a preliminary purchase price allocation prepared by a third party valuation expert. During the preliminary purchase price allocation period, which may be up to one year from the business combination date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. After the preliminary purchase price allocation period, the Company may record adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in its operating results in the period in which the adjustments were determined.
Pro forma results
The following table sets forth the unaudited pro forma results of the Company as if the acquisition of the Oasis LLCs was effective on the first day of each of the three and six months periods presented. These combined results are not necessarily indicative of the results that may have been achieved had the companies always been combined.
Three months ended November 30, | ||||||||
2018 | 2017 | |||||||
(unaudited) | (unaudited) | |||||||
Revenues | $ | 1,976,910 | $ | 1,928,265 | ||||
Net loss | $ | (10,771,264 | ) | $ | (10,734,044 | ) | ||
Basic net income per share | $ | (0.12 | ) | $ | (0.18 | ) | ||
Diluted net income per share | $ | (0.12 | ) | $ | (0.18 | ) | ||
Weighted average shares - basic | 90,338,339 | 58,372,855 | ||||||
Weighted average shares - diluted | 90,338,339 | 58,372,855 |
Six months ended November 30, | ||||||||
2018 | 2017 | |||||||
(unaudited) | (unaudited) | |||||||
Revenues | $ | 3,843,783 | $ | 3,311,457 | ||||
Net loss | $ | (19,353,778 | ) | $ | (8,453,557 | ) | ||
Basic net income per share | $ | (0.24 | ) | $ | (0.25 | ) | ||
Diluted net income per share | $ | (0.24 | ) | $ | (0.25 | ) | ||
Weighted average shares - basic | 80,765,385 | 57,280,264 | ||||||
Weighted average shares - diluted | 80,765,385 | 57,280,264 |
Note 4 – In Good Health Loan and Option Transaction
On October 31, 2018, the Company, CLS Massachusetts, Inc., a Massachusetts corporation and a wholly-owned subsidiary of the Company (“CLS Massachusetts”), and In Good Health, Inc. (“IGH”), a Massachusetts not-for-profit corporation, which converted to a for-profit corporation on November 6, 2018 (the “Conversion”), entered into an Option Agreement (the “Option Agreement”). Under the terms of the Option Agreement, CLS Massachusetts has an exclusive option to acquire all of the outstanding capital stock of IGH (the “Option”) during the period beginning on the earlier of the date that is one year after the effective date of the Conversion and December 1, 2019, and ending on the date that is 60 days after such date (the “Option Period”). If CLS Massachusetts exercises the Option, the Company, a wholly-owned subsidiary of the Company and IGH will enter into a merger agreement (the form of which has been agreed to by the parties) (the “Merger Agreement”). At the effective time of the merger contemplated by the Merger Agreement, CLS Massachusetts will pay a purchase price of $47,500,000, subject to reduction as provided in the Merger Agreement, payable as follows: $35 million in cash, $7.5 million in the form of a five-year promissory note, and $5 million in the form of restricted common stock of the Company, plus $2.5 million as consideration for a non-competition agreement with IGH’s President, payable in the form of a five-year promissory note.
IGH and certain IGH stockholders holding sufficient aggregate voting power to approve the transactions contemplated by the Merger Agreement have entered into agreements pursuant to which such stockholders have, among other things, agreed to vote in favor of such transactions.
On October 31, 2018, as consideration for the Option, the Company made a loan to IGH (the “IGH Loan”), in the principal amount of $5,000,000 (the “IGH Loan Amount”), subject to the terms and conditions set forth in that certain Loan Agreement, dated as of October 31, 2018 between IGH as the borrower and the Company as the lender (the “IGH Loan Agreement”) (see note 8). The IGH Loan is evidenced by a secured promissory note of IGH (the “IGH Note Receivable”), which bears interest at the rate of 6% per annum and matures on October 31, 2021.
To secure the obligations of IGH to the Company under the Loan Agreement and the IGH Note Receivable, the Company and IGH entered into a Security Agreement dated as of October 31, 2018 (the “IGH Security Agreement”), pursuant to which IGH granted to the Company a first priority lien on and security interest in all personal property of IGH.
If the Company does not exercise the Option on or prior to the date that is 30 days following the end of the Option Period, the Loan Amount will be reduced to $2,500,000 as a break-up fee (the “Break-Up Fee”), except in the event of a Purchase Exception (as defined in the Option Agreement), in which case the Break-Up Fee will not apply and there will be no reduction to the Loan Amount.
Note 5 – Accounts Receivable
Accounts receivable was $78,419 and $0 at November 30, 2018 and May 31, 2018, respectively. No allowance for doubtful accounts was necessary during the three and six months ended November 30, 2018 and 2017.
Note 6 – Inventory
Inventory, consisting of material, overhead, labor, and manufacturing overhead, is stated at the lower of cost (first-in, first-out) or market, and consists of the following:
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
Raw materials | $ | 257,985 | $ | - | ||||
Finished goods | 612,999 | - | ||||||
Total | $ | 870,984 | $ | - |
Raw materials consist of cannabis plants and the materials that are used in our production process prior to being tested and packaged for consumption. Finished goods consist of pre-packaged materials previously purchased from other licensed cultivators and our manufactured edibles and extracts.
Note 7 – Prepaid Expenses
Prepaid expenses consisted of the following at February 28,November 30, 2018 and May 31, 2017:
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
Prepaid legal fees | $ | 1,410 | $ | 1,410 | ||||
Prepaid expenses | 11,188 | - | ||||||
Total | $ | 12,598 | $ | 1,410 |
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
Prepaid insurance | $ | 26 | $ | - | ||||
Prepaid advertising | 5,946 | - | ||||||
Prepaid license fees | 62,685 | - | ||||||
Prepaid legal fees | 1,410 | 1,410 | ||||||
Prepaid general and administrative expenses | 5,743 | - | ||||||
Deposits on inventory | 66,000 | - | ||||||
Deposits on exterior signs | 35,134 | - | ||||||
Total | $ | 176,944 | $ | 1,410 |
Note 48 – Security Deposit
PRH Note Receivable
During the year ended May 31, 2015, the Company loaned $500,000 (the “PRH Note”) to Picture Rock Holdings, LLC, a Colorado limited liability company (“PRH”). Pursuant to the PRH Note, as amended by the parties effective June 30, 2015, October 31, 2015, April 11, 2016, and May 31, 2016, PRH was expected to repay the principal due under the PRH Note in twenty (20) equal quarterly installments of Twenty Five Thousand Dollars ($25,000) commencing in the month following the month in which PRH commenced generating revenue at the grow facility, which commencement was originally anticipated to occur in the first quarter of 2017, and continuing until paid in full. We suspended our plans to proceed with the Colorado Arrangement due to regulatory delays and have not yet determined when we will pursue them again. Interest will accrue on the unpaid principal balance of the PRH Note at the rate of twelve percent (12%) per annum and will be paid quarterly in arrears commencing after such initial payment and continuing until paid in full. All outstanding principal and any accumulated unpaid interest due under the Note is due and payable on the five-year anniversary of the initial payment thereunder. In the event of default as defined in the agreements underlying the Note, all amounts under the Note shall be due and payable at once. During the year ended May 31, 2015, the Company recorded an impairment related to the note receivable in the amount of $500,000.
During the year ended May 31, 2018, the Company received a payment of $50,000 on the PRH Note. As a result, the Company has reduced the impairment of the note by $50,000 to reflect this payment. The Company had a security depositreceivable is recorded on the balance sheet as of November 30, 2018 in the amount of $0, net of allowance in the amount of $450,000.
IGH Note Receivable
On October 31, 2018, in connection with an option to purchase transaction (see note 4), the Company loaned $5,000,000 (the “IGH Note) to In Good Health, Inc., a Massachusetts not-for-profit corporation (“IGH”); on November 6, 2018, IGH converted to a for-profit corporation. This Note bears interest at the rate of 6% per annum. On March 1, 2020 (the “Initial Payment Date”), all accrued interest shall be added to the outstanding principal due hereunder and $50,000 at February 28,such amount shall be payable in eight equal quarterly installments, commencing on the Initial Payment Date, together with interest accruing after the Initial Payment Date. The IGH Note shall mature and all outstanding principal, accrued interest and any other amounts due hereunder, shall become due and payable in full on the third anniversary of the IGH Note. The IGH Note was issued in connection with a loan agreement and security agreement between the Company and IGH, and an option agreement between the Company and IGH, among others (the “IGH Option Agreement”), in both cases dated as of October 31, 2018 and May 31, 2017, respectively. This amount consisted of a depositthe other agreements and documents executed and/or delivered in connection therewith (collectively the “IGH Loan Documents”), and is secured by the collateral described in the Loan Documents and by such other collateral as may in the future be granted to the Holder to secure office and warehouse space. In August of 2017, the Company received a demand letter fromIGH Note. During the landlord requesting the forfeiture of the $50,000 security deposit, $10,000 in expenses, $15,699 in remaining rent due under the lease agreement and $30,000 to buy out the remaining amounts due under the lease; during the sixthree months ended November 30, 2017,2018, the Company wrote-off the security depositrecorded interest income in the amount of $50,000.
Note 59 – Property, Plant and Equipment
Property, plant and equipment consisted of the following at February 28,November 30, 2018 and May 31, 2017.
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
Computer equipment | $ | 2,674 | $ | 2,674 | ||||
Property and equipment, gross | 2,674 | 2,674 | ||||||
Less: accumulated depreciation | (2,453 | ) | (1,784 | ) | ||||
Property and equipment, net | $ | 221 | $ | 890 |
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
Office equipment | 135,138 | 2,674 | ||||||
Furniture and fixtures | 30,895 | - | ||||||
Leasehold improvements | $ | 802,204 | $ | - | ||||
Less: accumulated depreciation | (76,167 | ) | (2,674 | ) | ||||
Property, plant, and equipment, net | $ | 892,070 | $ | - |
During the six months ended November 30 2018, the Company acquired property, plant, and equipment with an aggregate fair value of $933,142 with the acquisition of Alternative Solutions, LLC. See note 3.
Depreciation expense totaled $223of property, plant, and equipment was $48,658 and $223 for the three months ended February 28,November 30, 2018 and 2017 respectively. Depreciation expense totaled $669of property , plant, and $669equipment was $76,167 and $446 for the ninesix months ended February 28,November 30, 2018 and 2017 respectively.
Note 710 – Intangible Assets
Intangible assets consisted of the following at February 28,November 30, 2018 and May 31, 2017.
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
Domain name | $ | 2,158 | $ | 2,158 | ||||
2,158 | 2,158 | |||||||
Less: accumulated amortization | (1,152 | ) | (828 | ) | ||||
Intangible assets, net | $ | 1,006 | $ | 1,330 |
November 30, 2018 | ||||||||||||
Accumulated | ||||||||||||
Gross | Amortization | Net | ||||||||||
Intellectual Property | $ | 319,600 | $ | (13,317 | ) | $ | 306,283 | |||||
License & Customer Relations | 990,000 | (20,624 | ) | 969,376 | ||||||||
Tradenames - Trademarks | 301,000 | (12,542 | ) | 288,458 | ||||||||
Non-compete Agreements | 27,000 | (5,626 | ) | 21,374 | ||||||||
Domain Names | 4,482 | (2,060 | ) | 2,422 | ||||||||
Total | $ | 1,642,082 | $ | (54,169 | ) | $ | 1,587,913 |
May 31, 2018 | ||||||||||||
Accumulated | ||||||||||||
Gross | Amortization | Net | ||||||||||
Intellectual Property | $ | - | $ | - | $ | - | ||||||
License & Customer Relations | - | - | - | |||||||||
Tradenames - Trademarks | - | - | ) | - | ||||||||
Non-compete Agreements | - | - | - | |||||||||
Domain names | 1,726 | (828 | ) | 898 | ||||||||
Total | $ | 1,726 | $ | (828 | ) | $ | 898 |
Total amortization expense charged to operations for the three months ended February 28,November 30, 2018 and 2017 was $108$31,413 and $108, respectively. Total amortization expense charged to operations for the ninesix months ended February 28,November 30, 2018 and 2017 was $324$52,364 and $324,$216, respectively. The domain name is being amortized over a period of 60 months.
Amount to be amortized during the twelve months ended November 30, | ||||
2019 | $ | 127,120 | ||
2020 | 119,796 | |||
2021 | 111,560 | |||
2022 | 111,560 | |||
2023 | 111,560 | |||
Thereafter | 1,006,317 | |||
$ | 1,587,913 |
Note 11 – Other Assets
Other assets included the Company closes on the acquisition, infollowing as of November 30, 2018 and May 2020, Alternative Solutions will be entitled to a $1,000,000 payment from the Company, if the existing dispensary operated by an Oasis LLC has maintained an average revenue of $20,000 per day during the 2019 calendar year.
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
Security deposits | 160,450 | - | ||||||
$ | 160,450 | $ | - |
Note 912 – Accounts Payable and Accrued Liabilities
Accrued expenses consisted of the following at February 28,November 30, 2018 and May 31, 2017.
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
Trade payables | $ | 575,546 | $ | 497,213 | ||||
Accrued payroll and related liabilities | 40,562 | 34,987 | ||||||
Deferred rent liability | 55,699 | 49,565 | ||||||
Total accounts payable and accrued liabilities | $ | 671,807 | $ | 581,765 |
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
Trade accounts payable | 661,217 | $ | 726,457 | |||||
Accrued payroll and payroll taxes | 196,785 | 44,465 | ||||||
Accrued liabilities | 513,908 | - | ||||||
Deferred rent liability | 137,707 | 55,699 | ||||||
Total | $ | 1,509,617 | $ | 826,621 |
Note 10 – Related Party Transactions
Notes Payable
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
On February 7, 2018, the Company issued a note payable to Todd Blatt in the amount of $210,000 the “Blatt Note”). This note accrues interest at a rate of 6% per annum and is due on February 7, 2019. During the six months ended November 30, 2018, the Company accrued interest in the amount of $1,726 on the Blatt Note. On July 20, 2018, the Company made principal and interest payments in the amount of $210,000 and $5,627, respectively, on the Blatt Note. | $ | - | $ | 210,000 | ||||
On February 7, 2018, the Company issued a note payable to AJG Group in the amount of $200,000 the “AJG Note”). This note accrues interest at a rate of 6% per annum and is due on February 7, 2019. During the six months ended November 30, 2018, the Company accrued interest in the amount of $641 on the AJG Note. On July 9, 2018, the Company made principal and interest payments in the amount of $100,000 and $3,337, respectively, on the AJG Note. | - | 100,000 | ||||||
Secured note payable to Serenity Wellness Enterprises, LLC, as nominee (“Oasis Note”). dated June 27, 2018 in the principal amount of $4,000,000 and bearing interest at a rate of 6% per annum was issued pursuant to the Membership Interest Purchase Agreement with Alternative Solutions. The note is due December 4, 2019, but may be prepaid at any time without penalty. The Oasis Note is secured by all of the membership interests in Alternative Solutions and the Oasis LLCs and by the assets of the Oasis LLCs.
The Company recognized an original issue discount of $189,180 on the Oasis Note. During the six months ended November 30, 2018, $56,213 of this discount was charged to operations. During six months ended November 30, 2018, the Company accrued interest in the amount of $104,000 on the Oasis Note. | 4,000,000 | - | ||||||
Total – Notes Payable | $ | 4,000,000 | $ | 310,000 | ||||
Less: Discount | (132,967 | ) | - | |||||
Notes Payable, Net of Discounts | $ | 3,867,033 | $ | 310,000 | ||||
Current portion | $ | 3,867,033 | $ | 310,000 | ||||
Long term portion | $ | - | $ | - |
Related Party
Convertible Demand Notes PayableOn May 31, 2017, the Company entered into an Omnibus Loan Amendment Agreement (the “Omnibus Loan Amendment”) with Jeffrey I. Binder, Frank Koretsky, Newcan Investment Partners LLC and CLS CO 2016, LLC (collectively, the “Insiders”). Pursuant to the Omnibus Loan Amendment, the Company agreed with the Insiders to amend certain terms of loans the Insiders made to the Company for working capital purposes, which loans were initially demand loans, and, except for loans made in 2017, were later memorialized as convertible loans (the “Insider Loans”), in exchange for the agreement of the Insiders to convert all Insider Loans where funds were advanced prior to January 1, 2017, which totaled $2,537,750, plus $166,490 of accrued interest thereon, into an aggregate of 10,816,960 shares of the Company’s common stock at $0.25 per share, and forego the issuance of warrants to purchase the Company’s common stock upon conversion. This resulted in the issuance of an additional 7,609,910 shares compared to the original number of shares issuable upon conversion of the Insider Loans prior to the Omnibus Loan Agreement.Amendment. The Company valued the shares at $0.125, which was the market price of the Company’s stock at the conversion date, and charged the amount of $951,239 to loss on modification of debt during the twelve months ended May 31, 2017. The Company entered into the Omnibus Loan Amendment in order to ease the debt burden on the Company and prevent it from defaulting on the Insider Loans.
Pursuant to the Omnibus Loan Amendment, the following amendments were made to the Insider Loans: (a) the Company reduced the conversion price on the Insider Loans from between $0.75 and $1.07 per share of common stock to $0.25 per share of common stock, in those cases where the conversion price was greater than $0.25, which reduced conversion price exceeded the closing price of the common stock during the three months prior to the Omnibus Loan Amendment; (b) the Company deleted the requirement to issue warrants to purchase the Company’s common stock upon conversion of the Insider Loans; (c) the Company amended one Insider Loan to permit conversion of only the portion of the Insider Loan related to services that were provided to it prior to January 1, 2017; and (d) the Company amended the terms of the Insider Loans where funds were advanced on or after January 1, 2017, which Insider Loans were not converted into the Company’s common stock, to provide for, where not already the case, a 10% interest rate per annum, a $0.25 conversion price per share of common stock, and the deletion of the requirement that the Company issue warrants to purchase its common stock upon conversion of such Insider Loans.
On January 10, 2018, effective December 1, 2017, the Company entered into an Omnibus Amendment to Convertible Notes (the “Second Omnibus Loan Agreement”) with Jeffrey I. Binder, an officer and director of the Company, and Newcan Investment Partners LLC, an entity owned by Frank Koretsky, a director of the Company. The Second Omnibus Loan Agreement provides that the conversion price of all outstanding convertible promissory notes issued to either Mr. Binder or Newcan Investment Partners, LLC as of the date of the Agreement would be increased from $0.25 to $0.3125 per share of common stock. The remaining terms of such notes remain unchanged.
The following tables summarize the Company’s loan balances at February 28,November 30, 2018 and May 31, 2017:
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
Notes payable to Jeffrey Binder, an officer and director of the Company, for advances to fund operations (the “Binder Funding Notes”). The Binder Funding Notes bear interest at a rate of 6% for loans made through November 30, 2016, and at a rate of 10% for loans made after November 30, 2016. The Binder Funding Notes have no maturity date and are due on demand. During the twelve months ended May 31, 2016, Mr. Binder advanced a total of $95,250 to the Company under the Binder Funding Notes; during the year ended May 31, 2016, $92,500 of this amount was transferred out of the Binder Funding Notes and used to fund two new convertible notes payable to Mr. Binder (See Binder Convertible Notes 1 and 2 below). During the twelve months ended May 31, 2016, the Company accrued interest in the amount of $1,308 on the Binder Funding Notes. In July 2016, the remaining principal balance of $2,750 in the Binder Funding Notes was transferred to a new Convertible Note payable to Mr. Binder (the “Binder Convertible Note 3”). During the twelve months ended May 31, 2017, Mr. Binder advanced a total of $145,850 to the Company under the Binder Funding Notes. Also during the year ended May 31, 2017, Mr. Binder loaned the Company an additional $49,700; which was credited to the Binder Funding Notes. Also during the year ended May 31, 2017, principal in the amount of $59,750 and accrued interest in the amount of $813 was transferred out of the Binder Funding Notes and used to fund two new convertible notes payable to Mr. Binder (See Binder Convertible Notes 3 and 4 below). Also during the year ended May 31, 2017, the Company made principal payments in the aggregate amount of $61,000 under the Binder Funding Notes. During the year ended May 31, 2017, the Company accrued interest in the amount of $1,910 on the Binder Funding Notes. Effective May 31, 2017, pursuant to the Omnibus Loan Agreement, a conversion feature was added to the Binder Funding Notes whereby principal and accrued interest is convertible into common stock of the Company at a rate of $0.25 per share. During the three months ended August 31, 2017, Mr. Binder advanced a total of $47,767 to the Company under the Binder Funding Notes. During the three months ended August 31, 2017, interest in the amount of $2,466 was accrued on the Binder Funding Notes. Also during the three months ended August 31, 2017, principal in the amount of $77,550 and accrued interest in the amount of $3,630 were transferred from the Binder Funding Notes to a new convertible note payable to Mr. Binder (the “Binder Convertible Note 5”), and principal in the amount of $47,767 was transferred from the Binder Funding Notes to a new Convertible Note payable to Mr. Binder (the “Binder Convertible Note 6”). During the three months ended November 30, 2017, Mr. Binder advanced a total of $112,862 to the Company under the Binder Funding Notes. A discount in the amount of $70,790 related to the beneficial conversion feature of the Binder Funding Notes was charged to additional paid-in capital and amortized to interest expense. During these three months ended November 30, 2017, interest in the amount of $642 was accrued on the Binder Funding Notes. Also during the three months ended November 30, 2017, principal in the amount of $27,021 and accrued interest in the amount of $122 was transferred from the Binder Funding Notes to a new convertible note payable to Mr. Binder (the “Binder Convertible Note 7”). Effective December 1, 2017, pursuant to the Second Omnibus Loan Amendment, the conversion price was increased from $0.25 per share to $0.3125 per share and a discount in the amount of $35,023 related to the revaluation of the beneficial conversion feature of the Binder Funding Notes was charged to additional paid-in capital and amortized to interest expense. During three months ended February 28, 2018, Mr. Binder advanced a total of $194,191 to the Company under the Binder Funding Notes. During the three months ended February 28, 2018, interest in the amount of $2,433 was accrued on the Finder Funding Notes. A discount in the amount of $194,191 related to the beneficial conversion feature of the Binder Funding Notes was charged to additional paid-in capital and amortized to interest expense. Also, during the three months ended February 28, 2018, principal in the amount of $127,860 and accrued interest in the amount of $1,437 was transferred from the Binder Funding Notes to a new convertible note payable to Mr. Binder (the “Binder Convertible Note 8”). | $ | 152,174 | $ | 77,550 |
November 30, | May 31, | |||||||
2018 | 2018 | |||||||
Notes payable to Jeffrey Binder, an officer and director of the Company, for advances to fund operations (the “Binder Funding Notes”). The Binder Funding Notes bear interest at a rate of 10% per annum, have no maturity date and are due on demand. Effective May 31, 2017, pursuant to the Omnibus Loan Amendment, a conversion feature was added to the Binder Funding Notes whereby principal and accrued interest is convertible into common stock of the Company at a rate of $0.25 per share.
Effective December 1, 2017, pursuant to the Second Omnibus Loan Amendment, the conversion price was increased from $0.25 per share to $0.3125 per share and a discount in the amount of $35,023 related to the revaluation of the beneficial conversion feature of the Binder Funding Notes was charged to additional paid-in capital and amortized to interest expense.
During the twelve months ended May 31, 2018, Mr. Binder advanced a total of $440,579 to the Company under the Binder Funding Notes. During the year ended May 31, 2018, principal in the amount of $280,198 and accrued interest in the amount of $5,188 was transferred out of the Binder Funding Notes and used to fund four new convertible notes payable to Mr. Binder, which were converted or repaid as of May 31, 2018. Also during the year ended May 31, 2018 the Company made principal payments in the aggregate of $237,794 under the Binder Funding Notes. During the year ended May 31, 2018, the Company accrued interest in the amount of $7,364 on the Binder Funding Notes. During the year ended May 31, 2018, discounts in the amount of $385,637 related to the beneficial conversion feature of the Binder Funding Notes was charged to additional paid-in capital and amortized to interest expense.
During the six months ended November 30, 2018, Mr. Binder advanced a total of $158,615 to the Company under the Binder Funding Notes. During the six months ended November 30, 2018, the Company made principal payments to in the amount of $109,876 under the Binder Funding Notes. During the six months ended November 30, 2018, the Company accrued interest in the amount of $979 on the Binder Funding Notes. During the six months ended November 30, 2018, discounts in the aggregate amount of $158,615 related to the beneficial conversion feature of the Binder Funding Notes were charged to additional-paid in capital and amortized to interest expense. | $ | 48,874 | $ | 137 |
February 28, 2018 | May 31, 2017 | |||||||
Note payable to Frank Koretsky, a director of the Company, for advances to fund operations (the “Koretsky Funding Notes”). The Koretsky Funding Notes bear interest at a rate of 6% for loans made through November 30, 2016, and at a rate of 10% for loans made after November 30, 2016. The Koretsky Funding Notes have no maturity date and are due on demand. During the twelve months ended May 31, 2017, Mr. Koretsky advanced $550,000 to the Company under the Koretsky Funding Notes. Also during the twelve months ended May 31, 2017, $210,000 of principal and $1,346 of accrued interest was transferred out of the Koretsky Funding Notes and used to fund a new convertible notes payable to Mr. Koretsky. Also during the twelve months ended May 31, 2017, principal and accrued interest in the amounts of $410,000 and $4,046, respectively, were transferred out of the Koretsky Funding Notes and contributed to the Newcan Funding Notes (see Newcan Funding Notes, below). | - | - | ||||||
Notes payable to Newcan Investment Partners, LLC (“Newcan”), an entity owned by Frank Koretsky, a director of the Company, for advances to fund operations (the “Newcan Funding Notes”). The Newcan Funding Notes bear interest at a rate of 10%. The Newcan Funding Notes have no maturity date and are due on demand. During the twelve months ended May 31, 2017, principal and interest in the amount of $410,000 and $4,046, respectively, were transferred from the Koretsky Funding Notes into the Newcan Funding Notes. Also during the year ended May 31, 2017, Newcan advanced $791,658 to the Company under the Newcan Funding Notes. Also during the year ended May 31, 2017, principal in the amount of $460,000 and accrued interest in the amount of $7,747, respectively, were transferred from the Newcan Finding Notes and used to fund the Newcan Convertible Notes 2 and 3 (see below); also during the year ended May 31, 2017, principal and accrued interest in the amounts of $120,000 and $2,121, respectively, were transferred out of the Newcan Funding Notes in order to fund the Newcan Convertible Note 3; see below. During the twelve months ended May 31, 2017, the Company accrued interest in the amount of $13,434 on this note. Effective May 31, 2017, pursuant to the Omnibus Loan Agreement, a conversion feature was added to the Newcan Funding Notes whereby principal and accrued interest is convertible into common stock of the Company at a rate of $0.25 per share. During the three months ended August 31, 2017, Newcan advanced $70,000 to the Company under the Newcan Funding Notes. Also during the three months ended August 31, 2017, interest in the amount of $14,964 was accrued on the Newcan Funding Notes. Also during the three months ended August 31, 2017, principal in the amount of $621,658 and accrued interest in the amount of $23,856 were transferred to a new Convertible Note payable to Newcan (the “Newcan Convertible Note 4”), and principal in the amount of $70,000 was transferred to a new Convertible Note payable to Newcan (the “Newcan Convertible Note 5”). During the three months ended November 30, 2017, Newcan advanced $45,000 to the Company under the Newcan Funding Notes. Also during the three months ended November 30, 2017, interest in the amount of $247 was accrued on the Newcan Funding Notes. A discount in the amount of $58,600 related to the beneficial conversion feature of the Binder Funding Notes was charged to additional paid-in capital and amortized to interest expense. Also, during the three months ended November 30, 2017, principal in the amount of $30,000 and accrued interest in the amount of $148 were transferred to a new Convertible Notes payable to Newcan (the “Newcan Convertible Note 6”). Effective December 1, 2017, pursuant to the Second Omnibus Loan Amendment, the conversion price was increased from $0.25 per share to $0.3125 per share and a discount in the amount of $6,120 related to the revaluation of the beneficial conversion feature of the Newcan Funding Notes was charged to additional paid-in capital and amortized to interest expense. During the three months ended February 28, 2018, Newcan advanced $100,000 to the Company under the Newcan Funding Notes. Also during the three months ended February 28, 2018, interest in the amount of $915 was accrued on the Newcan Funding Notes. A discount in the amount of $70,400 related to the beneficial conversion feature of the Newcan Funding Notes was charged to additional paid-in capital and amortized to interest expense. Also, during the three months ended February 28, 2018, principal in the amount of $115,000 and accrued interest in the amount of $1,014 were transferred to a new Convertible Notes payable to Newcan (the “Newcan Convertible Note 6”). | - | 621,658 | ||||||
Total – Demand Convertible Notes Payable, Related Parties | $ | 152,174 | $ | 699,208 | ||||
Current portion | $ | 152,174 | $ | 699,208 | ||||
Long term portion | $ | - | $ | - |
November 30, 2018 | May 31, 2018 | |||||||
Notes payable to Newcan Investment Partners, LLC (“Newcan”), an entity owned by Frank Koretsky, a director of the Company, for advances to fund operations (the “Newcan Funding Notes”). The Newcan Funding Notes bear interest at a rate of 10% per annum, have no maturity date and are due on demand. Effective May 31, 2017, pursuant to the Omnibus Loan Agreement, a conversion feature was added to the Newcan Funding Notes whereby principal and accrued interest is convertible into common stock of the Company at a rate of $0.25 per share.
Effective December 1, 2017, pursuant to the Second Omnibus Loan Amendment, the conversion price was increased from $0.25 per share to $0.3125 per share and a discount in the amount of $6,120 related to the revaluation of the beneficial conversion feature of the Newcan Funding Notes was charged to additional paid-in capital and amortized to interest expense.
During the twelve months ended May 31, 2018, Newcan advanced a total of $290,000 to the Company under the Newcan Funding Notes. During the year ended May 31, 2018, principal in the amount of $836,658 and accrued interest in the amount of $25,018 was transferred out of the Newcan Funding Notes and used to fund four new convertible notes payable to Newcan, which were converted or repaid as of May 31, 2018.). During the year ended May 31, 2018, the Company accrued interest in the amount of $16,681 on the Newcan Funding Notes. During the year ended May 31, 2018, discounts in the amount of $210,120 related to the beneficial conversion feature of the Newcan Funding Notes was charged to additional paid-in capital and amortized to interest expense.
During the six months ended November 30, 2018, principal in the amount of $75,000 and accrued interest in the amount of $1,931 was transferred out of the Newcan Funding Notes and used to create a new convertible note payable to Newcan (“Newcan Convertible Note 8”). During the six months ended November 30, 2018, the Company accrued interest in the amount of $1,377 on the Newcan Funding Notes. | - | 75,000 | ||||||
Total – Demand Convertible Notes Payable, Related Parties | $ | 48,874 | $ | 75,137 | ||||
Total – Demand Convertible Notes Payable, Related Parties - Current portion | $ | 48,874 | $ | 75,137 | ||||
Total – Demand Convertible Notes Payable, Related Parties - Long term portion | $ | - | $ | - |
February 28, | May 31, | |||||||
2018 | 2017 | |||||||
Unsecured convertible note issued to Jeffrey Binder, an officer and director of the Company, dated March 31, 2017 (the “Binder Convertible Note 4”). The Binder Convertible Note 4 was funded with the conversion of $112,500 of unpaid accrued salary due to Mr. Binder and $47,000 of advances Mr. Binder made to the Company under the Binder Funding Notes. This note bears interest at the rate of 10% per annum. No interest payments are required until April 1, 2018, at which time all accrued interest becomes due and payable. Commencing on July 1, 2018, the first of eight principal payments in the amount of $19,938 will become due; subsequent principal payments will become due on the first day of each October, January, April, and July until paid in full. This note and accrued interest under the note may be converted, in whole or in part, into one “Unit” for each $0.25 converted, with each Unit consisting of one (1) share of common stock and a five-year warrant to purchase (1) share of common stock at a price of $0.25 per share. Pursuant to the Omnibus Loan Agreement, on May 31, 2017, the requirement to issue warrants upon conversion was deleted, and principal in the amount of $87,500 was converted into a total of 350,000 shares of common stock. The remaining principal balance of $72,000 will be due in eight quarterly payments in the amount of $9,000 commencing July 1, 2018; subsequent principal payments will become due on the first day of each October, January, April, and July until paid in full. During the twelve months ended May 31, 2017, the Company accrued interest in the amount of $2,666 on the Binder Convertible Note 4. Effective December 1, 2017, pursuant to the Second Omnibus Loan Amendment, the conversion price was increased from $0.25 per share to $0.3125 per share and a discount was recorded in the amount of $29,376 related to the revaluation of the beneficial conversion feature of the Binder Convertible Note 4; $2,628 of this discount was amortized to interest expense during the three months ended February 28, 2018.. During the three and nine months ended February 28, 2018, interest in the amount of $1,775 and $5,385 was accrued on Binder Convertible Note 4, respectively. | $ | 72,000 | $ | 72,000 | ||||
Unsecured convertible note issued to Newcan, an entity owned by Frank Koretsky, a director of the Company, dated March 31, 2017 (the “Newcan Convertible Note 3”). The Newcan Convertible Note 3 was funded with the conversion of $120,000 of advances made to the Company under the Newcan Funding Notes. This note bears interest at the rate of 10% per annum. No interest payments are required until April 1, 2018, at which time all accrued interest becomes due and payable. Commencing on July 1, 2018, the first of eight principal payments in the amount of $15,000 will become due; subsequent principal payments will become due on the first day of each October, January, April, and July until paid in full. This note and accrued interest under the note may be converted, in whole or in part, into one “Unit” for each $0.25 converted, with each Unit consisting of one (1) share of common stock and a five-year warrant to purchase (1) share of common stock at a price of $0.25 per share. During the twelve months ended May 31, 2017, the Company accrued interest in the amount of $2,005 on the Koretsky Convertible Note 4. Pursuant to the Omnibus Loan Agreement, on May 31, 2017, the requirement to issue warrants upon conversion was deleted. Effective December 1, 2017, pursuant to the Second Omnibus Loan Amendment, the conversion price was increased from $0.25 per share to $0.3125 per share and a discount was recorded in the amount of $48,960 related to the revaluation of the beneficial conversion feature of the Newcan Convertible Note 1; $4,379 of this discount was amortized during the three months ended February 28, 2018. During the three and nine months ended February 28, 2018, interest in the amount of $2,959 and $8,975 was accrued on Newcan Convertible Note 3, respectively. | 120,000 | 120,000 |
Convertible Notes Payable, Related Parties
November 30, 2018 | May 31, 2018 | |||||||
Convertible promissory note payable to David Lamadrid (the “Lamadrid Note”) dated February 20, 2018 in the principal amount of $31,250 and bearing interest at a rate of 8% per annum. The Lamadrid Note is due eighteen months from the date of issue. Mr. Lamadrid may, at his option, convert all or a portion of the Lamadrid Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Lamadrid Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Lamadrid Note will be reset to such lower price. The Company recognized a discount of $31,250 on the Lamadrid Note related to the beneficial conversion feature at the time of issuance. During the twelve months ended May 31, 2018, $942 of this discount was charged to operations. During the twelve months ended May 31, 2018, the Company accrued interest in the amount of $685 on this note.
During the six months ended November 30, 2018, interest in the amount of $562 was accrued on the Lamadrid note. During the six months ended November 30, 2018, the Lamadrid Note, in the amount of $$32,497, of which $31,250 was principal and $1,247 was accrued interest, was converted into 103,989 shares of common stock. During the six months ended November 30, 2018 the remaining discount in the amount of $30,308 was charged to operations. | $ | - | $ | 31,250 | ||||
Unsecured convertible note issued to Jeffery Binder, an officer and director of the Company, dated April 6, 2018 in the original principal amount of $37,500 (the “Binder Convertible Note 9”). The Binder Convertible Note 9 was funded with the conversion of $37,500 of unpaid accrued salary due to Mr. Binder. This note bears interest at the rate of 10% per annum. No interest payments are required until July 1, 2019, at which time all accrued interest becomes due and payable. Commencing October 1, 2019, the first of eight principal payments in the amount of $4,688 will become due; subsequent payments will become due on the first day of each January, April, July and October until paid in full. This note and accrued interest under the note may be converted, in whole or in part, into one share of common stock for each $0.3125 converted. The Company recognized a discount of $37,500 on the Binder Convertible Note 9 related to the value of the beneficial conversion feature at the time of issuance. During the twelve months ended May 31, 2018, the Company amortized $1,890 of this discount to interest expense.
During the twelve months ended May 31, 2018 and 2017, interest in the amount of $565 and $0 was accrued on Binder Convertible Note 9, respectively.
During the six months ended November 30, 2018, interest in the amount of $699 was accrued on the Binder Convertible Note 9. During the six months ended November 30, 2018, the Company made a principal payment in the amount of $37,500 on the Binder Convertible Note 9. During the six months ended November 30, 2018 the remaining discount in the amount of $35,610 was charged to operations. | - | 37,500 |
November 30, 2018 | May 31, 2018 | |||||||
Unsecured convertible note issued to Newcan, an entity owned by Frank Koretsky, a director of the Company, dated, August 6, 2018 in the original amount of $75,000 (the “Newcan Convertible Note 8”). The Newcan Convertible Note 8 was funded with the conversion of $75,000 of advances Newcan made to the Company under the Newcan Funding Notes. This note bears interest at the rate of 10% per annum. No interest payments are required until January 1, 2020, at which time all of the accrued interest becomes due and payable. Commencing on January 1, 2020, the first of eight principal payments in the amount of $9,375 will become due; subsequent principal payments will become due on the first day of each April, July, October, and January until paid in full. This note and accrued interest under the note may be converted, in whole or in part, into one share of common stock for each $0.40 converted. The Company recognized a discount of $58,594 on the Newcan Convertible Note 8 related to the value of the beneficial conversion feature at the time of issuance.
During the six months ended November 30, 2018, the Company accrued interest expense in the amount of $1,603 on this note. During the six months ended November 30, 2018, the note holder converted $78,534, of which $75,000 was principal and $3,534 was accrued interest into 196,336 shares of common stock. Also during the six months ended November 30, 2018, the remaining discount in the amount of $57,322 was charged to interest expense | - | - | ||||||
Total – Convertible Notes Payable, Related Parties | $ | - | $ | 68,750 | ||||
Less: Discount | - | (65,918 | ) | |||||
Convertible Notes Payable, Related Parties, Net of Discounts | $ | - | $ | 2,832 | ||||
Convertible Notes Payable, Related Parties, Net of Discounts, Current Portion | $ | - | $ | 2,832 | ||||
Convertible Notes Payable, Related Parties, Net of Discounts, Long-term Portion | - | - |
Convertible Notes Payable
November 30, 2018 | May 31, 2018 | |||||||
Convertible promissory note payable to Darling Capital, LLC (the “Darling Note”) dated February 5, 2018 and bearing interest at a rate of 8% per annum. The lender loaned the Company $500,000 and the Darling Note has an original issue discount of $50,000. The Darling Note is due eighteen months from the date of issue. Darling may, at its option, convert all or a portion of the Darling Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Darling Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Darling Note will be reset to such lower price. The Company recognized a discount of $550,000 on the Darling Note related to the beneficial conversion feature at the time of issuance. During the twelve months ended May 31, 2018, $40,427 of this discount was charged to operations. During the twelve months ended May 31, 2018, the Company accrued interest in the amount of $13,863 on this note.
During the six months ended November 30, 2018, the Company accrued interest in the amount of $1,447 on this note. During the six months ended November 30, 2018, the holder of the Darling Note converted $565,000, of which $550,000 was principal and $15,000 was accrued interest, into 1,808,000 shares of common stock. Also during the six months ended November 30, 2018, the remaining discount in the amount of $509,573 was charged to operations. | $ | - | $ | 550,000 | ||||
Convertible promissory note payable to Efrat Investments, LLC (the “Efrat Note”) dated February 12, 2018 and bearing interest at a rate of 8% per annum. The lender loaned the Company $50,000 and the Efrat Note has an original issue discount of $5,000. The Efrat Note is due eighteen months from the date of issue. Efrat may, at its option, convert all or a portion of the Efrat Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Efrat Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Efrat Note will be reset to such lower price. The Company recognized a discount of $55,000 on the Efrat Note related to the beneficial conversion feature at the time of issuance. During the twelve months ended May 31, 2018, $2,974 of this discount was charged to operations. During the twelve months ended May 31, 2018, the Company accrued interest in the amount of $1,302 on this note.
During the six months ended November 30, 2018, the Company accrued interest in the amount of $898 on this note. During the six months ended November 30, 2018, the holder of the Efrat Note converted $57,200, of which $55,000 was principal and $2,200 was accrued interest into 183,040 shares of common stock. Also during the six months ended November 30, 2018, the remaining discount in the amount of $52,026 was charged to operations. | - | 55,000 |
November 30, 2018 | May 31, 2018 | |||||||
Convertible promissory note payable to YA II PN, Ltd. (the “YA II PN Note”) dated May 14, 2018 and bearing interest at a rate of 8% per annum. The lender loaned the Company $750,000, and the note is due on November 14, 2019. YA II PN may, at its option, convert all or a portion of the YA II PN Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.40 per share. The YA II PN Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.40 per share of common stock, the conversion price of the YA II PN Note will be reset to such lower price. The Company recognized a discount of $750,000 related to the beneficial conversion feature at the time of issuance. Commencing on December 1, 2018, absent certain exceptions, the first of eight payments in the amount of $93,750 will become due; subsequent payments will become due on the first day of each of the following months until paid in full. During the twelve months ended May 31, 2018, $23,224 of this discount was charged to operations. During the twelve months ended May 31, 2018, the Company accrued interest in the amount of $2,795 on this note.
During the six months ended November 30, 2018, a reset event occurred. As a result, the conversion price of the YA II PN Note was reduced to $0.34 per share of common stock. This was considered a material modification of the note; the remaining balance of the discount to the note in the amount of $699,628 was charged to interest expense, a new discount in the amount of $750,000 was charged to additional paid-in capital, and $124,581 of the new discount was amortized to interest expense. Also during the six months ended November 30, 2018, the Company accrued interest expense in the amount of $29,205 on the YA II PN Note. During the six months ended November 30, 2018, the holder of the YA II PN Note converted principal in the amount of $250,000 and accrued interest in the amount of $30,247 into 700,616 shares of common stock. | 500,000 | 750,000 | ||||||
Unsecured convertible note issued to Jay Lasky (the “Lasky Note”), dated May 3, 2018 in the original principal amount of $25,000. This note bears interest at the rate of 10% per annum. No interest payments are required until July 1, 2019, at which time all accrued interest becomes due and payable. Commencing on October 1, 2019, the first of eight principal payments in the amount of $3,125 will become due; subsequent payments will become due on the first day of each January, April, July and October until paid in full. The Lasky Note and accrued interest under the note may be converted, in whole or in part, into one share of common stock for each $0.40 converted. The Company recognized a discount of $7,301 on the Lasky Note related to the beneficial conversion feature at the time of issuance. During the twelve months ended May 31, 2018, $149 of this discount was charged to operations. During the twelve months ended May 31, 2018, the Company accrued interest in the amount of $192 on this note.
During the six months ended November 30, 2018, $7,152 of the discount was charged to operations. Also during the six months ended November 30, 2018, the Company accrued interest in the amount of $993 on this note. During the six months ended November 30, 2018, the holder of the Lasky Note converted $26,185, of which $25,000 was principal and $1,185 was accrued interest into 65,462 shares of common stock. | - | 25,000 |
November 30, 2018 | May 31, 2018 | |||||||
Convertible promissory note | - | |||||||
Convertible debenture in the principal amount of $4,000,000 (the “U.S. Convertible Debenture 1”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 1. The U.S. Convertible Debenture 1 matures on a date that is three years following issuance. The U.S. Convertible Debenture 1 is convertible |
- | ||||||||
Convertible debenture in the principal amount of $1,000,000 (the “U.S. Convertible Debenture 2”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 2. The U.S. Convertible Debenture 2 matures on a date that is three years following issuance. The U.S. Convertible Debenture 2 is convertible | - |
November 30, 2018 | May 31, 2018 | |||||||
Convertible debenture in the principal amount of $100,000 (the “U.S. Convertible Debenture 3”) dated October 24, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 3. The U.S. Convertible Debenture 3 matures on a date that is three years following issuance. The U.S. Convertible Debenture 3 is convertible | - | |||||||
Convertible debenture in the principal amount of $532,000 (the “U.S. Convertible Debenture 4”) dated October 25, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 4. The U.S. Convertible Debenture 4 matures on a date that is three years following issuance. The U.S. Convertible Debenture 4 is convertible | - |
February 28, 2018 | May 31, 2017 | |||||||
Unsecured convertible note issued to Newcan, an entity owned by Frank Koretsky, a director of the Company, dated, January 5, 2018 in the original amount of $115,000 (the “Newcan Convertible Note 7”). The Newcan Convertible Note 7 was funded with the conversion of $115,000 of advances Newcan made to the Company under the Newcan Funding Notes. This note bears interest at the rate of 10% per annum. No interest payments are required until April 1, 2019, at which time all of the accrued interest becomes due and payable. Commencing on July 1, 2019, the first of eight principal payments in the amount of $14,375 will become due; subsequent principal payments will become due on the first day of each October, January, April and July until paid in full. This note and accrued interest under the note may be converted, in whole or in part, into one share of common stock for each $0.3125 converted. The Company recognized a discount of $115,000 on the Newcan Convertible Note 7 related to the value of the beneficial conversion feature at the time of issuance. During the three months ended February 28, 2018, the Company amortized $5,254 of this discount to interest expense. During the three and nine months ended February 28, 2018, interest in the amount of $1,701 was accrued on the Newcan Convertible Note 7. | 115,000 | - | ||||||
Unsecured convertible note issued to Jeffery Binder, an officer and director of the Company, dated January 5, 2018 in the original principal amount of $165,360 (the “Binder Convertible Note 8”). The Binder Convertible Note 8 was funded with the conversion of $37,500 of unpaid accrued salary due to Mr. Binder and $127,860 of advances Mr. Binder made to the Company under the Binder Funding Notes. This note bears interest at the rate of 10% per annum. No interest payments are required until April 1, 2019, at which time all accrued interest becomes due and payable. Commencing July 1, 2019, the first of eight principal payments in the amount of $20,670 will become due; subsequent payments will become due on the first day of each October, January, April and July until paid in full. This note and accrued interest under the note may be converted, in whole or in part, into one share of common stock for each $0.3125 converted. The Company recognized a discount of $165,360 on the Binder Convertible Note 8 related to the value of the beneficial conversion feature at the time of issuance. During the three months ended February 28, 2018, the Company amortized $7,555 of this discount to interest expense. During the three and nine months ended February 28, 2018, interest in the amount of $2,446 and $2,446 was accrued on Binder Convertible Note 8, respectively. | 165,360 | - | ||||||
Convertible promissory note payable to David Lamadrid (the “Lamadrid Note”) dated February 20, 2018 in the principal amount of $31,250 and bearing interest at a rate of 8% per annum. The Lamadrid Note is due eighteen months from the date of issue. Mr. Lamadrid may, at his option, convert all or a portion of the Lamadrid Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Lamadrid Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Lamadrid Note will be reset to such lower price. The Company recognized a discount of $31,250 on the Lamadrid Note related to the beneficial conversion feature at the time of issuance. During the three months ended February 28, 2018, $458 of this discount was charged to operations. During the three months ended February 28, 2018, the Company accrued interest in the amount of $55 on this note. | 31,250 | - | ||||||
Total – Convertible Notes Payable, Related Parties | $ | 1,452,606 | $ | 192,000 | ||||
Less: Discount | (722,229 | ) | - | |||||
Convertible Notes Payable, Related Parties, Net of Discounts | $ | 730,377 | $ | 192,000 | ||||
Convertible Notes Payable, Related Parties, Net of Discounts, Current Portion | $ | 114,803 | $ | - | ||||
Convertible Notes Payable, Related Parties, Net of Discounts, Long-term Portion | 615,574 | 192,000 |
February 28, 2018 | May 31, 2017 | |||||||
Convertible promissory note issued to an unaffiliated third party due April 29, 2018 (the “April 2015 Note”). During the twelve months ended May 31, 2015, the lender loaned the Company the amount of $200,000 pursuant to this note. The April 2015 Note bears interest at a rate of 15% per annum. On the first anniversary of this note, the all then accrued interest became due. Thereafter, the Company is required to make eight equal payments of principal together with accrued interest, quarterly in arrears, commencing on July 1, 2016 until paid in full. The note and any accrued unpaid interest is convertible into common stock of the Company. For each dollar converted, the note holder shall receive two shares of common stock and one three-year warrant to purchase 1.33 shares of common stock at $0.75 per share. The Company recognized a discount of $200,000 on the April 2015 Note related to the value of the beneficial conversion feature at the time of issuance. During the twelve months ended May 31, 2016, $66,667 of this discount was charged to operations. During the twelve months ended May 31, 2016, the Company accrued interest in the amount of $30,082 on this note. During the year ended May 31, 2017, the Company repaid principal in the amount of $100,000 and interest in the amount of $53,837 on this note. Also during the year ended May 31, 2017, the Company charged $100,545 of the discount to operations, and accrued interest in the amount of $22,440 on the April 2015 Note. On September 20, 2017, the Company entered into an Exchange Agreement, whereby it agreed to exchange the April 2015 Note for 1,500,000 shares of its common stock. The holder of the April 2015 Note had previously sold it for $105,219, which represented the balance due by the Company, to StarForce Media, Inc., an entity that is not affiliated with the Company. The Company recognized a loss on this exchange in the amount of $404,082, which was charged to operations during the three months ended November 30, 2017. The Company also expensed the remaining discount in the amount of $18,155 to interest expense during the three months ended November 30, 2017. During the three and nine months ended February 28, 2018 the Company accrued interest in the amount of $ 0 and $4,603, respectively, on the April 2015 Note. | $ | - | $ | 100,000 |
Convertible | 150,000 | - |
February 28, 2018 | May 31, 2017 | |||||||
Senior Convertible promissory note payable to FirstFire Global Opportunities Fund, LLC (the “FirstFire Note”) dated November 15, 2017 and bearing interest at a rate of 5% per annum. The lender loaned the Company $330,000 and the FirstFire Note has an original issue discount of $33,000. The FirstFire Note is due seven months from the date of issue. FirstFire may, at its option, convert all or a portion of the FirstFire Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.40 per share (the “FirstFire Fixed Conversion Price”) for the first 180 calendar days after the issue date. After the 180th day, the conversion price shall equal the lower of (i) the FirstFire Fixed Conversion Price, or (ii) 75% multiplied by the lowest traded price of the common stock during twenty (20) consecutive trading day period immediately preceding the trading day that the Company received a notice of conversion. During the three months ended February 28, 2018, a dilutive issuance occurred. As a result, the FirstFire Fixed Conversion Price was reduced to $0.3125 per share. The Company recognized a discount of $363,000 on the FirstFire Note related to the beneficial conversion feature at the time of issuance. During the three and nine months ended February 28, 2018, $86,362 and $116,445, respectively, of this discount was charged to operations. During the three and nine months ended February 28, 2018, the Company accrued interest in the amount of $4,475 and $5,221 on this note, respectively. | 363,000 | - | ||||||
Convertible promissory note payable to Darling Capital, LLC (the “Darling Note”) dated February 5, 2018 and bearing interest at a rate of 8% per annum. The lender loaned the Company $500,000 and the Darling Note has an original issue discount of $50,000. The Darling Note is due eighteen months from the date of issue. Darling may, at its option, convert all or a portion of the Darling Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Darling Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Darling Note will be reset to such lower price. The Company recognized a discount of $550,000 on the Darling Note related to the beneficial conversion feature at the time of issuance. During the three months ended February 28, 2018, $23,168 of this discount was charged to operations. During the three months ended February 28, 2018, the Company accrued interest in the amount of $2,773 on this note. | 550,000 | - | ||||||
Convertible promissory note payable to Efrat Investments, LLC (the “Efrat Note”) dated February 12, 2018 and bearing interest at a rate of 8% per annum. The lender loaned the Company $50,000 and the Efrat Note has an original issue discount of $5,000. The Efrat Note is due eighteen months from the date of issue. Efrat may, at its option, convert all or a portion of the Efrat Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Efrat Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Efrat Note will be reset to such lower price. The Company recognized a discount of $55,000 on the Efrat Note related to the beneficial conversion feature at the time of issuance. During the three months ended February 28, 2018, $1,612 of this discount was charged to operations. During the three months ended February 28, 2018, the Company accrued interest in the amount of $193 on this note. | 55,000 | - | ||||||
Total - Convertible Notes Payable | $ | 968,000 | $ | 310,000 | ||||
Less: Discount | (826,775 | ) | (57,644 | ) | ||||
Convertible Notes Payable, Net of Discounts | $ | 141,225 | $ | 252,356 | ||||
Total - Convertible Notes Payable, Net of Discounts, Current Portion | $ | 141,225 | $ | 252,356 | ||||
Total - Convertible Notes Payable, Net of Discounts, Long-term Portion | $ | - | $ | - |
November 30, 2018 | May 31, 2018 | |||||||
Convertible debenture payable in the principal amount of $75,000 (the “U.S. Convertible Debenture 6”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 6. The U.S. Convertible Debenture 6 matures on a date that is three years following issuance. The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The U.S. Convertible Debenture 6 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 6 is an unsecured obligation of the Company and ranks pari passu in right of payment of principal and interest with all other unsecured obligations of the Company. The Company recorded a discount in the amount of $60,049 on the U.S. Convertible Debenture 6. During the six months ended November 30, 2018, $19 of this discount was charged to operations. During the six months ended November 30, 2018, the Company accrued interest in the amount of $575 on the U.S. Convertible Debenture 6. | 75,000 | - | ||||||
Total - Convertible Notes Payable | $ | 6,857,000 | $ | 1,380,000 | ||||
Less: Discount | (5,343,875 | ) | (1,295,527 | ) | ||||
Convertible Notes Payable, Net of Discounts | $ | 1,513,125 | $ | 84,473 | ||||
Total - Convertible Notes Payable, Net of Discounts, Current Portion | $ | 396,813 | $ | 43,401 | ||||
Total - Convertible Notes Payable, Net of Discounts, Long-term Portion | $ | 1,116,312 | $ | 41,072 |
Discounts on notes payable amortized to interest expense – 3 months ended | $ | 1,598,501 |
Discounts on notes payable amortized to interest expense – | $ | 2,144,333 |
Beneficial Conversion Features
The 8% Note, FirstFire Note, Darling Note, Efrat Note, and Lamadrid Note and YA II PN Notes contain conversion features that create derivative liabilities. The pricing model the Company uses for determining fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income. The derivative componentcomponents of the 8% Note wasnotes were valued at issuance, at conversion, at restructure, and at each period end. See note 11.
Certain of the Company’s other convertible notes payable contain beneficial conversion features that are not derivatives, but which require valuation in order to determine the discount to the related convertible note payable. The value of these conversion features is calculated using the intrinsic value method, whereby the amount of the discount is calculated as the difference between the conversion price and the market price of the underlying common stock at the date of issuance multiplied by the number of shares issuable.
Note 1214 – Contingent Liability
The terms of the Company’s acquisition of Alternative Solutions, LLC include a payment of $1,000,000 contingent upon the Oasis LLCs achieving certain revenue targets. (see note 3). The fair value of this contingent consideration at the time of the Acquisition Agreement was $678,111 as determined by the Company’s outside valuation consultants. Management has reviewed the value of the contingent consideration, and has concluded that no adjustment is necessary at November 30, 2018,
Note 15 – Stockholders’ Equity
The Company’s authorized capital stock consists of 250,000,000 shares of common stock, par value $0.0001 per share and 20,000,000 shares of preferred stock, par value $0.001 per share. The Company had 43,186,94491,150,451 and 32,852,94450,128,972 shares of common stock issued and outstanding as of February 28,November 30 2018 and May 31, 2017,2018, respectively.
The Company recorded imputed interest of $265$271 and $265$271 during the three months ended February 28,November 30, 2018 and 2017 on related party payables due to a director and officer of the Company. The Company recorded imputed interest of $804$539 and $804$539 during the ninesix months ended February 28,November 30, 2018 and 2017 on related party payables due to a director and officer of the Company.
Stock Issued upon Conversion of Notes Payable
During the threesix months ended February 28, 2017, Old Main,November 30, 2018, Darling Capital, holder of a convertible promissory notes,note, converted an aggregatea total of $100,000$565,000, which consisted of $550,000 of principal in six transactions,and $15,000 of accrued interest, into 828,1731,808,000 shares of common stock. As
During the six months ended November 30, 2018, Efrat Investments, holder of a resultconvertible promissory note, converted a total of $57,200, which consisted of $55,000 of principal and $2,200 of accrued interest, into 183,040 shares of common stock.
During the conversions,six months ended November 30, 2018, David Lamadrid, holder of a convertible promissory note, converted a total of $32,497, which consisted of $31,250 of principal and $1,247 of accrued interest, into 103,989 shares of common stock.
During the Company chargedsix months ended November 30, 2018, Jay Lasky, holder of a convertible promissory note, converted a total of $26,185, which consisted of $25,000 of principal and $1,185 of accrued interest, into 65,462 shares of common stock.
During the amount $222,574 to additional paid-in capital. six months ended November 30, 2018, Newcan, holder of a convertible promissory note, converted a total of $78,534, which consisted of $75,000 of principal and $3,534 of accrued interest, into 196,336 shares of common stock.
During the six months ended November 30, 2018, YA II PN, holder of a convertible promissory note, converted a total of $280,247, which consisted of $250,000 of principal and $30,247 of accrued interest, into 700,616 shares of common stock.
On July 13, 2017,24, 2018, the Company issued 24,000 sharesawarded Star Associates, LLC, a limited liability company owned by Andrew Glashow, a director of common stock tothe Company, a consultant in exchange for a $6,000 accrued liability for services previously provided. This resulted in a gain on the settlement of accounts payablecash payment in the amount of $3,480.
On June 24, 2018, pursuant to the terms of a severance agreement between the Company and David Lamadrid, the Company issued 600,000 shares of itsrestricted common stock to Mr. Lamadrid. These shares were valued at $510,000. The holder$264,000, $213,320 of which was previously expensed and the April 2015 Note had previously sold it for $105,219, which represented the balance due by the Company, to StarForce Media, Inc., an entity that is not affiliated with the Company. The Company recognized a loss on this exchange in the amountremaining $50,680 of $404,082, which was charged to operations during the ninesix months ended February 28,November 30, 2018.
On September 25, 2017,11, 2018, the Company entered into an Exchange Agreement, whereby it agreedissued 31,250 shares of common stock with a fair value of $25,310 in exchange for legal services previously rendered to exchange the 8% NoteCompany. These shares were accrued on February 8, 2018, and were issued from stock payable.
Stock Issued for 4,500,000Acquisition
On June 27, 2018, the Company issued 22,058,823 shares of its common stock pursuant to the terms of the Alternative Solutions, LLC Acquisition Agreement. These shares were valued at $1,844,035.$15,441,176. (See note 3).
Special Warrants Issued in Offering
On June 20, 2018, the Company executed an Agency Agreement with Canaccord Genuity Corp. and closed on a private offering of its special warrants for aggregate gross proceeds of C$13,037,859 (USD$9,785,978). Pursuant to the offering, the Company issued 28,973,020 special warrants at a price of C$0.45 (USA$0.34) per special warrant. Each special warrant was automatically exercisable, for no additional consideration, into units of the Company on the earlier of: (i) the date that was five business days following the date on which the Company obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of the Company's acquisition of all of the membership interests in Alternative Solutions, LLC, known as Oasis Cannabis.
In connection with the offering, the Company paid Canaccord Genuity Corp. a cash commission equal to C$1,043,028 (USD$799,053), a corporate finance fee equal to 1,448,651 special warrants, and 2,317,842 compensation broker warrants valued at $1,495,373. Each compensation broker warrant entitles the holder thereof to acquire one unit at a price of C$0.45 per unit for a period of 36 months from the date that the Company's common stock is listed on a recognized Canadian stock exchange, subject to adjustment in certain events. The Company recognized a loss on this exchange in the amount of $989,032, which was1,448,651 special warrants that were issued were valued at $1,413,300 and were charged to operations during the ninethree months ended February 28,August 31, 2018.
Upon exercise of the Company issued 250,000 sharesspecial warrants, each unit was to consist of restricted Common Stock, valued at $95,000, as a commitment fee to a convertible note holder.
Because the Company did not receive a receipt from the applicable Canadian securities authorities for the qualifying prospectus by August 20, 2018, the Company received gross proceedsunexercised special warrants were adjusted to entitle the holders to receive 1.1 units instead of $1,087,500 fromone unit of the WestPark Offering, of which $146,975 were expenses, resulting in net proceeds of $940,525, from the sale of units.Company. This resulted in the planned issuance of 3,480,000an additional 3,042,167 units. This penalty was valued at $7,142,550 and was charged to operations during the three months ended August 31, 2018.
On November 30, 2018, all of the special warrants were automatically converted into 33,465,110 shares of common stock and 870,000 warrants to purchase 33,465,110 shares of common stock for CD$0.65 per share.
Stock Issued in Navy Capital Offering
On July 31, 2018, the Company entered into a Subscription Agreement with Navy Capital Green International, Ltd, (the “Navy Capital Offering”) for 7,500,000 units at a price of $0.75.
In connection with the Navy Capital Offering, between August 8, 2018 and August 10, 2018, the Company entered into five subscription agreements for a total of 6,875,000 units at a price of $0.75.
Stock Issued to Officers
On July 27, 2018, the net proceedsCompany granted 25,000 shares of this salerestricted common stock to its Chief Financial Officer. These shares vested four months after issuance. The shares were valued at $17,500, and were amortized over the vesting period. As of November 30, 2018, these shares had not yet been received by the Company,issued. As of November 30, 2018, $17,500 had been charged to operations, and the amount of $69,102 is recordedcarried as common stock subscriptions receivableCommon Stock Subscribed on the Company’s balance sheet.
On July 31, 2018, the Company granted the Chief Executive Officer of CLS Nevada, Inc. a one-time signing bonus of 500,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement. These shares were valued at $350,000 and will be amortized over the vesting period. As of November 30, 2018, $147,917 had been charged to operations, and is carried as Common Stock Subscribed on the Company’s balance sheet at November 30, 2018.
On July 31, 2018, the Company granted the Chief Operating Officer of CLS Nevada, Inc. a one-time signing bonus of 50,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement. These shares were valued at $35,000 and will be amortized over the vesting period. As of November 30, 2018, $14,792 had been charged to operations, and is carried as Common Stock Subscribed on the Company’s balance sheet at November 30, 2018.
Stock Issued upon Cashless Exercise of Warrants
On August 14, 2018, the Company issued 129,412 shares of common stock for the cashless conversion of 350,000 warrants at an exercise price of $0.75 per share.
On September 6, 2018, the Company issued 13,684 shares of common stock upon the cashless exercise of 40,000 warrants at an exercise price of $0.75 per share.
On November 15, 2017,14, 2018, the Company issued 5,867 shares of common stock upon the cashless exercise of 25,000 warrants at an exercise price of $0.75 per share.
Stock Issued for Settlement
On November 1, 2018, the Company issued 50,000 shares of common stock with a fair value of $47,500 pursuant to a legal settlement. There was no gain or loss associated with this transaction.
Additional Paid-in Capital
During the six months ended November 30, 2018, the Company recorded discounts on two convertible notes payable relating to beneficial conversion features in the aggregate amount of $362,500 on the YA II PN Note 2, and $58,594 on the Newcan Convertible Note 8. Also during the six months ended November 30, 2018, a reset event occurred with regard to the YAII PN Note.
During the six months ended November 30, 2018, the Company recorded an original issue discount on the Serenity Wellness Note in the amount of $81,961.
On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in the previously issued convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to additional paid-in capital in the aggregate amount of $1,265,751. On June 20, 2018, a reset event occurred in connection with the Company’s saleYA II PN Note (see note 13), and the Company charged the change in fair value of the conversion feature in the amount of $35,833 to additional paid-in capital. This was considered a material modification of the note, and the Company created a new discount to this note in the amount of $750,000, which was charged to additional paid-in capital.
During the six months ended November 30, 2018, the Company recorded discounts on six convertible debenture,debentures relating to beneficial conversion features as follows: a discount of $3,254,863 was recorded on the U.S. Convertible Debenture 1; a discount of $813,696 was recorded on the U.S. Convertible Debenture 2; a discount of $75,395 was recorded on the U.S. Convertible Debenture 3; a discount of $416,627 was recorded on the U.S. Convertible Debenture 4; a discount of $120,078 was recorded on the U.S. Convertible Debenture 5; and a discount of $60,030 was recorded on the U.S. Convertible Debenture 6.
Warrants
On June 27, 2018, the Company incurred a penalty in connection with the WestPark Offering due to the late filing of the registration statement that included the resale of the securities that were sold in such offering. As a result of the penalty, the Company issued FirstFire Global Opportunities Fund, LLC (“FirstFire”) a three-year common stock purchase warrantwarrants to purchase 350,000an aggregate of 1,368,250 shares of the Company’s common stock at an initial exercise price of $0.50 per share. In addition, the Company reduced the exercise price of the common stock purchase warrants previously issued to the investors in the WestPark Offering from $0.75 per share to $0.50 per share. The fair value of the penalty was $941,972; this amount was charged to operations during the three months ended August 31, 2018.
On June 20, 2018, in connection with the special warrant offering, the Company issued Canaccord Genuity Corp. 2,317,842 three-year broker warrants at an exercise price of C$0.45 per share as compensation. Each warrant entitles the holder to purchase one unit, which consists of one share of common stock and a warrant to purchase one share of common stock, for C$0.65 per share. These warrants were valued at $123,950$1,495,373, and werethis amount was charged to operations during the ninethree months ended February 28,August 31, 2018.
On February 9,July 20, 2018, in connection with the Company’s sale of a convertible debenture, the Company issued Darling Capital (“Darling”)to YA II PN, Ltd. a three-yearfive-year common stock purchase warrant to purchase 400,0001,250,000 shares of the Company’s common stock at an initial exercise price of $0.75$0.60 per share. These warrants were valued at $313,128 and were charged to operations during the nine months ended February 28, 2018.
On February 16, 2018, in connection with the Company’s sale of a convertible debenture, the Company issued Efrat Investments (“Efrat”) a three-year common stock purchase warrant to purchase 40,000 shares of the Company’s common stock at an initial exercise price of $0.75 per share. These warrants were valued at $32,076 and were charged to operations during the nine months ended February 28, 2018.
On February 21,August 8, 2018, the Company issued three-year common stock purchase warrants to purchase an aggregate of 80,0006,875,000 shares of the Company’s common stock at an exercise price of $0.75$0.60 per share, to investors in the WestParkNavy Capital Offering.
The following table summarizes the significant terms of warrants outstanding at February 28,November 30, 2018. These warrants were granted as part of financing agreements:
Weighted | Weighted | Weighted | ||||||||||||||||||||
average | average | average | ||||||||||||||||||||
Range of | Number of | remaining | exercise | exercise | ||||||||||||||||||
exercise | warrants | contractual | price of | Number of | price of | |||||||||||||||||
Prices | Outstanding | life (years) | outstanding Warrants | warrants Exercisable | exercisable Warrants | |||||||||||||||||
$ | 0.75 | 1,480,000 | 2.99 | $ | 0.75 | 1,480,000 | $ | 0.75 | ||||||||||||||
1,480,000 | 2.99 | $ | 0.75 | 1,480,000 | $ | 0.75 |
Range of exercise Prices | Number of warrants Outstanding | Weighted average remaining contractual life (years) | Weighted average exercise price of outstandingWarrants |
Number of warrantsExercisable | Weighted average exercise price of exercisableWarrants | |||||||||||||||||
$ | 0.49 | 35,782,952 | 2.97 | $ | 0.49 | 35,782,952 | $ | 0.49 | ||||||||||||||
0.50 | 2,736,500 | 3.23 | 0.50 | 2,736,500 | 0.50 | |||||||||||||||||
0.60 | 17,500,000 | 3.00 | 0.60 | 17,500,000 | 0.60 | |||||||||||||||||
0.75 | 1,042,738 | 2.62 | 0.75 | 1,042,738 | 0.75 | |||||||||||||||||
57,062,190 | 2.98 | $ | 0.53 | 57,062,190 | $ | 0.53 |
Transactions involving warrants are summarized as follows:follows. This table does not include the special warrants; see Special Warrant section below.
Number of Shares | Weighted Average Exercise Price | |||||||
Warrants outstanding at May 31, 2018 | 4,700,988 | $ | 0.62 | |||||
Granted | 52,776,202 | $ | 0.58 | |||||
Exercised | (415,000 | ) | $ | 0.75 | ||||
Cancelled / Expired | - | $ | - | |||||
Warrants outstanding at November 30, 2018 | 57,062,190 | $ | 0.53 |
Number of Shares | Weighted Average Exercise Price | |||||||
Warrants outstanding at May 31, 2017 | - | $ | - | |||||
Granted | 1,480,000 | $ | 0.75 | |||||
Exercised | - | $ | - | |||||
Cancelled / Expired | - | $ | - | |||||
Warrants outstanding at February 28, 2018 | 1,480,000 | $ | 0.75 |
Special Warrants
On June 20, 2018, the Company sold 28,973,019 special warrants for net proceeds of US$9,785,978. Each special warrant was automatically exercisable, for no additional consideration, into units of the Company on the earlier of: (i) the date that was five business days following the date on which the Company obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of the Company's acquisition of all of the membership interests in Alternative Solutions, LLC, known as Oasis Cannabis, which was June 28, 2018.
All of the special warrants were automatically exercised for units on November 30, 2018. Each unit consists of one share of the Company’s common stock and one three-year warrant to purchase one share of common stock at a price of CAN$0.65.
Note 1316 – Fair Value of Financial Instruments
The Company has issued convertible notes containing beneficial conversion features to Old Main, Darling, Efrat, David Lamadrid and FirstFire. The Old Main 8% Note was satisfied during the three months ended November 30, 2017, along with the derivative liability associated with the Old Main 8% Note. See note 11.YA II PN Notes. One of the features is a ratchet reset provision which, in general, reduces the conversion price should the Company issue equity with an effective price per share that is lower than the stated conversion price in the note. The Company accounts for the fair value of the conversion feature in accordance with ASC 815- Accounting for Derivatives and Hedging and Emerging Issues Task Force (“EITF”) 07-05- Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock (“EITF 07-05”). The Company carries the embedded derivative on its balance sheet at fair value and accounts for any unrealized change in fair value as a component of its results of operations.
The following summarizes the Company’s derivative financial liabilities that are recorded at fair value on a recurring basis at February 28,November 30, 2018 and May 31, 2017.
February 28, 2018 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Liabilities | ||||||||||||||||
Derivative liabilities | $ | - | $ | - | $ | 974,175 | $ | 974,175 |
May 31, 2017 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Liabilities | ||||||||||||||||
Derivative liabilities | $ | - | $ | - | $ | 95,276 | $ | 95,276 |
November 30, 2018 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Liabilities | ||||||||||||||||
Contingent liabilities | $ | - | $ | - | $ | 678,111 | $ | 678,111 |
May 31, 2018 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Liabilities | ||||||||||||||||
Derivative liabilities | $ | - | $ | - | $ | 1,265,751 | $ | 1,265,751 |
The estimated fair values of the Company’s derivative liabilities are as follows:
Derivative | ||||
Liability | ||||
Liabilities Measured at Fair Value | ||||
Balance as of May 31, 2017 | $ | 95,276 | ||
Issuances | 3,091,039 | |||
Conversions/Redemptions | (2,238,003 | ) | ||
Revaluation loss | 25,863 | |||
Balance as of February 28, 2018 | $ | 974,175 |
Derivative | ||||
Liability | ||||
Liabilities Measured at Fair Value | ||||
Balance as of May 31, 2018 | $ | 1,265,751 | ||
Transfers out due to the adoption of ASU 2017-11 effective June 1, 2018 | (1,265,751 | ) | ||
Balance as of November 30 2018 | $ | - |
Note 1417 – CommitmentCommitments and Contingencies
In connection with the Colorado Arrangement, on April 17, 2015, pursuant to an Industrial Lease Agreement (the “Lease”), CLS Labs Colorado leased 14,392 square feet of warehouse and office space (the “Leased Real Property”) in a building in Denver, Colorado where certain intended activities, including growing, extraction, conversion, assembly and packaging of cannabis and other plant materials, are permitted by and in compliance with state, city and local laws, rules, ordinances and regulations. The Lease hashad an initial term of seventy-two (72) months and providesprovided CLS Labs Colorado with two options to extend the term of the lease by up to an aggregate of ten (10) additional years. In August 2017, as a result of the Company’s decision to suspend its proposed operations in Colorado, CLS Labs Colorado asked its landlord to be relieved from its obligations under the Lease, but the parties have not yet reached an agreement on how to proceed.
In August 2017, the Company’s Colorado subsidiary received a demand letter from its Colorado landlord requesting the forfeiture of the $50,000 security deposit, $10,000 in expenses, $15,699 in remaining rent due under the lease agreement and $30,000 to buy out the remaining amounts due under the lease. These expenses, which are a liability of the Company’s Colorado subsidiary, have been accrued on the balance sheet as of February 28,November 30, 2018.
Employment Agreements
CLS Labs and Jeffrey Binder entered into a five-year employment agreement effective October 1, 2014. Under the agreement, Mr. Binder serves as CLS Labs’ Chairman President and Chief Executive Officer and is entitled to receive an annual salary of $150,000. Under the agreement, Mr. Binder is also entitled to receive a performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million. On April 28, 2015, CLS Labs and the Company entered into an addendum to Mr. Binder’s employment agreement whereby Mr. Binder agreed that following the merger of CLS Labs and a subsidiary of the Company, in addition to his obligations to CLS Labs, he would serve the Company and its subsidiaries in such roles as the Company may request. In exchange, the Company agreed to assume the obligations of CLS Labs to grant Mr. Binder annual stock options, as referenced above. Mr. Binder continues to receive an annual salary of $150,000 from CLS Labs for serving as its Chairman, President and Chief Executive Officer. My Binder has deferred all of the salary payable to him under his employment agreement through November 30, 2017. On July 20, 2016, March 31, 2017, August 23, 2017, October 9, 2017, and January 5, 2018 and April 6, 2018, the Company issued Mr. Binder convertible notes in exchange for $250,000, $112,500, $62,500, $39,521, $37,500 and $37,500 respectively, in deferred salary, among other amounts owed to Mr. Binder by the Company. As of February 28,November 30, 2018 and May 31, 2017,2018, the Company had accrued compensation due to Mr. Binder in the amount of 37,500$0 and $37,500.
Effective August 1, 2015, the Company and Alan Bonsett entered into a five-year employment agreement. Pursuant to the agreement, Mr. Bonsett commenced serving as the Company’s Chief Operating Officer on August 15, 2015. Under the agreement, Mr. Bonsett iswas entitled to receive an annual salary of $150,000. Further, he iswas entitled to receive a performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million. Additionally, Mr. Bonsett received a one-time signing bonus of 250,000 (post Reverse-Split) shares of restricted common stock of the Company, valued at $327,500, which became fully vested one year from the effective date of the agreement. Mr. Bonsett, as an owner of Picture Rock Holdings, LLC (“PRH”), willwas expected to indirectly receive the benefits of the Colorado Arrangement discussed in Note 12. The business to be operated by PRH pursuant to the Colorado Arrangement has not yet produced revenues.above. Mr. Bonsett agreed to defer his salary effective July 1, 2017; at February 28,November 30, 2018, the Company had accrued compensation due to Mr. Bonsett in the amount of $37,500. On October 1, 2017, the Company and Mr. Alan Bonsett, the Company’s Chief Operating Officer, mutually agreed to end his employment with the Company. Mr. Bonsett may provide consulting services to the Company in the future on an as needed basis.
Effective November 30, 2017, the Company and Mr. Lamadrid entered into a one-year employment agreement. Pursuant to the agreement, Mr. Lamadrid commenced serving as the Company’s President and Chief Financial Officer on December 1, 2017. Under the agreement, Mr. Lamadrid iswas entitled to receive an annual salary of $175,000. Further, he iswas entitled to receive a performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA. Additionally, Mr. Lamadrid iswas entitled to a one-time signing bonus of 500,000 shares of restricted common stock of the Company, which shallwere to become fully vested one year from the effective date of the agreement.
On July 31, 2018, the Company and Mr. Sillitoe entered into a one-year employment agreement. Pursuant to the agreement, Mr. Sillitoe commenced serving as the Chief Executive Officer of CLS Nevada, Inc. effective July 1, 2018. Under the agreement, Mr. Sillitoe is entitled to receive an annual salary of $150,000. Further, he is entitled to receive a performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of the annual EBITDA of CLS Nevada, Inc. Additionally, Mr. Sillitoe is entitled to a one-time signing bonus of 500,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement assuming Mr. Sillitoe remains employed by the Company on such date. As of November 30, 2018 and May 31, 2017,2018, the Company had accrued compensation due to Mr. Sillitoe in the amount of $25,000 and $0.
The Company and Mr. Decatur entered into a one-year employment agreement on July 31, 2018. Pursuant to the agreement, Mr. Decatur commenced serving as the Chief Operating Officer of CLS Nevada, Inc. on July 1, 2018. Under the agreement, Mr. Decatur is entitled to receive an annual salary of $150,000. Further, he is entitled to receive a performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’ common stock in an amount equal to 3% of the annual EBITDA of CLS Nevada, Inc. Additionally, Mr. Decatur is entitled to a one-time signing bonus of 50,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement assuming Mr. Decatur remains employed by the Company on such date.
At November 30, 2018 and May 31, 2018, the Company had accrued salary due to Michael Abrams, a former officer of the Company, prior to his September 1, 2015 termination, in the amount of $16,250.
Note 1518 – Subsequent Events
As of November 30, 2018 and May 31, 2018, the Company owed the amount of $0 and Alternative Solutions entered into a Third Amendment$37,500, respectively, to the Membership Interest Purchase Agreement (the “Third Amendment”)Jeffrey Binder, its Chief Executive Officer, for accrued salary.
As of November 30, 2018 and extended the date upon which the Company is to pay the “Oasis Note” by approximately one (1) year to DecemberMay 31, 2019. The Third Amendment also provides that the time period to determine average daily net revenue for the “Bonus Purchase Price”, is amended to be the calendar year ending December 31, 2019 with the payment due thereunder extended to May 30, 2020.
As of November 30, 2018 and May 31, 2018, the Company had accrued salary due to Michael Abrams, a $4.0 million promissory note due in December 2019 (the “Oasis Note”), and $6,000,000 in shares (the “Purchase Price Shares”)former officer of the Company’sCompany prior to his September 1, 2015 termination, in the amount of $16,250.
As of November 30, 2018 and May 31, 2018, the Company had related party payables in the amount of $17,930 due to officers and directors related to expenses paid on behalf of the Company. The Company imputed interest at the rate of 6% per annum on these liabilities, and recorded imputed interest expense on these liabilities in the amounts of $271 and $271 during the three months ended November 30, 2018 and 2017, respectively. These interest accruals were charged to additional paid-in capital.
On July 27, 2018, the Company granted 25,000 shares of restricted common stock (collectively, the “Closing Consideration”).
On July 31, 2018, the Company shall deliver to Alternative Solutionsgranted the Chief Executive Officer of CLS Nevada, Inc. a confessionone-time signing bonus of judgment that will become effective in the event of any event of default under the Oasis Note.
On July 31, 2018, the closing consideration, it will also be obligated to issue 500,000Company granted the Chief Operating Officer of CLS Nevada, Inc. a one-time signing bonus of 50,000 shares of its restricted common stock, to eachwhich shall become fully vested one year from the effective date of David Lamadrid, its Presidenthis employment agreement. These shares were valued at $35,000 and Chief Financial Officer, and J.P. Barton, for introducing the Company to Alternative Solutions.
On March 2,July 24, 2018, the Company entered intoawarded Star Associates, LLC, a consulting agreement with Starcity Capital, LLC to assist in its investor relations forlimited liability company owned by Andrew Glashow, a period of three months. Pursuant to the termsdirector of the consulting agreement,Company, a cash payment in the amount of $250,000 and 700,000 shares of restricted common stock in recognition of Mr. Glashow’s efforts, through Star Associates, in successfully assisting the Company issued 117,000in negotiating and obtaining the financing necessary to acquire Alternative Solutions, LLC. The shares were valued at $490,000 and were charged to operations during the three months ended August 31, 2018.
Note 19 – Subsequent Events
On MarchDecember 12, 2018, the Company received conversion notices forexecuted an Agency Agreement with certain Canadian agents (collectively, the related party notes payable“Agents”) regarding a private offering of up to CLS CO 2016, LLC, Newcan and Jeffery Binder. Frank Koretsky, the holder of the CLS CO 2016, LLC note, converted accrued interest in the amount of $9,308 into 29,786 shares of common stock. Jeffery Binder converted notes with an$40 million aggregate principal amount of $464,698senior unsecured convertible debentures (“Debentures”) with an issue price of US$1,000 per Debenture, convertible into units of the Company (the “Units”) at the option of the holder at a conversion price of US$0.80 per Unit at any time prior to the close of business on the earlier of: (i) the last business day immediately preceding the maturity date of the Debentures, being the date that is three (3) years from the closing date of the offering, and accrued interest(ii) the date fixed for redemption upon the occurrence of a Change of Control (as defined in the amount of $507,756 into 1,624,819 shares of common stock. Newcan, an entity owned by Mr. Koretsky, converted notes with an aggregate principal amount of $956,658 and accrued interest in the amount of $3,375,220 into 3,375,220 shares of common stock. Frank Koretsky also converted accrued interest on notes issued to him in the amount of $46,626 into 149,203 shares of common stock.
On April 6,December 12, 2018, the Company issued a convertible promissory note to Jeffrey Binder, an officer and directorclosed on the sale of the first tranche of Debentures, which was approximately $12 million.
On January 8, 2019, the Company in the amountreceived a conversion notice from a note holder converting $256,027, of $37,500.00 (the “Binder Convertible Note 8”), with respect to certain compensation payable to Mr. Binder as of February 28, 2018. The Note is unsecuredwhich $250,000 was principal and bears interest at the rate of 10% per annum. No payments are required until April 1, 2019, at which time all$6,027 was accrued interest, becomes due and payable. Principal will be paid in eight equal quarterly installments, together with interest accrued thereon, beginning on July 1, 2019. The Binder Convertible Note 8 may be prepaid by the Company with no penalty at any time upon thirty days written notice. Mr. Binder may, at any time prior to payment or prepayment in full, convert all principal and accrued interest thereunder, in whole or in part, into securities640,068 shares of the Company. For each $0.3125 converted, Mr. Binder will receive one share of the Company’s common stock.
OVERVIEW AND OUTLOOK
We were incorporated on March 31, 2011 as Adelt Design, Inc. to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced. On November 20, 2014, we adopted amended and restated articles of incorporation, thereby changing our name to CLS Holdings USA, Inc. Effective December 10, 2014, we effected a reverse stock split of our issued and outstanding common stock at a ratio of 1-for-0.625 (the “Reverse Split”), wherein 0.625 shares of our common stock were issued in exchange for each share of common stock issued and outstanding.
On April 29, 2015, the Company, CLS Labs and the Merger Sub consummated the merger, whereby the Merger Sub merged with and into CLS Labs, with CLS Labs remaining as the surviving entity. As a result of the merger, we acquired the business of CLS Labs and abandoned our previous business. As such, only the financial statements of CLS Labs are included in this annual report.
CLS Labs was originally incorporated in the state of Nevada on May 1, 2014 under the name RJF Labs, Inc. before changing its name to CLS Labs, Inc. on October 24, 2014. It was formed to commercialize a proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes (“e-cigarettes”), and used for a variety of pharmaceutical and other purposes. Testing in conjunction with two Colorado growers of this extraction method and conversion process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace.
On April 17, 2015, CLS Labs took its first step toward commercializing its proprietary methods and processes by entering into the Colorado Arrangement through its wholly owned subsidiary, CLS Labs Colorado, with certain Colorado entities, including PRH. Recently,Picture Rock Holdings, LLC (“PRH”), an entity affiliated with one of our former officers. During 2017, we suspended our plans to proceed with the Colorado Arrangement due to regulatory delays and have not yet determined if or when we will pursue itthem again. Instead, we plan to pursue other revenue producing opportunities, including the Acquisition Agreement with Alternative Solutions, as described below, in other states through the acquisition of cannabis and other complementary companies.
We recently receivedhave been issued a Notice of Allowance from the U.S. Patent and Trademark Officepatent with respect to our patent applicationproprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes, and used for our proprietarya variety of pharmaceutical and other purposes. Internal testing of this extraction method and conversion methodology.process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace. We have not yet commercialized our proprietary processprocess. We plan to generate revenues through licensing, fee-for-service and have not earned any revenues.
We intend to monetize our extraction and conversion method and generate revenues through (i) the licensing of our patent pending proprietary methods and processes to others, (ii) the processing of cannabis for others, and (iii) the purchase of cannabis and the processing and sale of cannabis-related products. We plan to accomplish this through the acquisition of companies, the creation of joint ventures, through licensing agreements, and through fee-for-service arrangements with growers and dispensaries of cannabis products. We believe that we can establish a position as one of the premier cannabinoid extraction and processing companies in the industry. Assuming we do so, we then intend to explore the creation of our own brand of concentrates for consumer use, which we would sell wholesale to cannabis dispensaries. We believe that we can create a “gold standard” national brand by standardizing the testing, compliance and labeling of our products in an industry currently comprised of small, local businesses with erratic and unreliable product quality, testing practices and labeling. We also plan to offer consulting services through Cannabis Life Sciences Consulting, LLC, which will generate revenue by providing consulting services to cannabis-related businesses, including growers, dispensaries and laboratories, and driving business to our processing facilities.
On December 4, 2017, we entered into a Membership Interest Purchase Agreement (the “Acquisition Agreement”) with Alternative Solutions to acquire the outstanding equity interests in three of its subsidiaries (collectively, the “Oasis LLCs”); Serenity Wellness Center LLC d/b/a/ Oasis Medical Cannabis, pursuantSerenity Wellness Growers LLC, and Serenity Wellness Products LLC. Pursuant to the Acquisition Agreement, as described below,amended, we paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 on February 5, 2018, for an initial 10% of Alternative Solutions and each of the subsidiaries. At the closing of our mission has shifted to becomingpurchase of the remaining 90% of the ownership interests in Alternative Solutions and the Oasis LLCs, which occurred on June 27, 2018, we paid the following consideration: $5,995,543 in cash, a fully licensed$4.0 million promissory note due in December 2019, and $6,000,000 in shares of our common stock. The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because we assumed an additional $204,457 of liabilities. The Oasis LLCs collectively own and operate a vertically integrated cannabis producer and retailerbusiness, including one dispensary, in Nevada and other western states. Our strategy and business model will be similar to Canopy Growth (WEED.TO), Aurora Cannabis (ACB.TO) and GB Sciences (GBLX). CLS stands for “Cannabis Life Sciences,” in recognition of our patent pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. Our business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
On January 4, 2018, the Attorney General of the United States issued new written guidance concerning the enforcement of federal laws relating to marijuana. The Attorney General’s memorandum stated that previous DOJ guidance specific to marijuana enforcement, including the memorandum issued by former Deputy Attorney General James Cole on August 29, 2013 (as amended on February 14, 2014, the “Cole Memo”) is unnecessary and is rescinded, effective immediately. The Cole Memo told federal prosecutors that in states that had legalized marijuana, they should use their prosecutorial discretion to focus not on businesses that comply with state regulations, but on illicit enterprises that create harms like selling drugs to children, operating with criminal gangs, and selling across state lines. In addition, since 2014, the federal budget has prohibited the DOJ from using federal funds to prosecute medical cannabis businesses pursuant to a budget rider, which must be renewed annually and is presently setunrenewed due to expire on January 19, 2018.the stalemate over funding the government for fiscal year 2019. The Attorney General has now advised that it will be left to the discretion of the local US attorneys in the various districts to decide how and when to enforce the federal marijuana laws. As a result of the Attorney General’s recent guidance, it is unclear whether and how US attorneys in states with medical and/or recreational marijuana laws will enforce federal laws relating to the prohibition of the possession, ownership or sale of marijuana, among other things. It is also unclear whether any states will challenge the Attorney General’s new pronouncement in the applicable courts. However, as a result of the Attorney General’s new guidance, some banks, clearing brokers and other businesses may cease or limit how they do business with companies in the marijuana business to avoid a possible violation of federal law. It is also possible that some US attorneys may begin enforcing federal laws to prevent marijuana businesses that are otherwise validly operating under state laws, from conducting business. Thus, regardless of whether the Attorney General’s new pronouncement is enforced or found to be lawful, it could have a material adverse impact on the marijuana industry, including our business.
Results of Operations for the Three Months Ended February 28,November 30, 2018 and 2017
Revenues
We had no revenues of $1,976,910 and $0 during the three months periods ended February 28,November 30, 2018 and February 28,November 30, 2017.
GeneralCost of goods sold
Our cost of goods sold for the three months ended November 30, 2018 was $1,046,667 compared to cost of goods sold of $0 for the three months ended November 30, 2017. The increase in cost of goods sold for the three months ended November 30 2018 is due to our acquisition of the Oasis LLCs. Cost of goods sold consisted of $1,019,567 of product cost, $21,984 of licensing fees, $2,386 of supplies and materials, and $2,730 of freight. Our gross margin for the three months ended November 30, 2018 was 47%.
Selling, general and administrative expenses
Selling, general and administrative expenses increased $693,843,by $2,719,657, or approximately 4481%1,057%, to $838,047$2,977,036 during the three months ended February 28,November 30, 2018, compared to $144,204$257,379 for the three months ended February 28,November 30, 2017. GeneralThe increase in selling, general, and administrative costs was attributable primarily to the costs associated with the Oasis LLCs, which we acquired effective June 27, 2018. The following increases in selling, general, and administrative expenses consistedwere associated entirely with the Oasis LLCs: office and facilities expense increased by $202,499; depreciation and amortization increased by $76,259; and insurance expense increased by $38,296. The following increases in selling, general, and administrative expenses were attributable primarily of general office expenses,to the Oasis LLCs: Professional fees increased by $780,242; payroll and related costs increased by $605,393; sales, marketing, and advertising costs increased by $445,986; stock based compensation increased by $158,250; taxes and licenses increased by $109,419; and travel costs rent expense, compensationincreased by $76,552. The addition of the Oasis LLCs caused us to add $627,834 to payroll and related costs, bank charges and payroll expenses.$115,985 to sales, marketing and advertising cost, which contributed to the increase in overall selling, general and administrative costs. The increase in stock based compensation was primarily duelargely related to $610,414 incurredrestricted stock we granted to three of our officers, two of whom work with the value of the warrants issuedOasis LLCs. Although we expect expenses related to placement agent for the private offering and $55,000 in stock compensation awardedfundraising activities to an officervary depending on the Company. Weour future growth, we expect operational general and administrative expenses to increase in future periods as we implement our business plan and commence operations.
Professional fees
Interest expense for the three months ended February 28,November 30, 2018 was $1,434,314, an increase$652,450, a decrease of $1,053,165,$154,515, or 276%19%, compared to $381,149$806,965 for the three months ended February 28,November 30, 2017. Interest expense increased primarily due to $477,195 of interest expense associated with the discount and warrants issued with the Darling Note; $50,035 of interest expense associated with the discount and warrants issued with the Efrat Note; and $24,827 of interest expense associated with the discount and warrants issued with the Lamadrid Note. During the three months ended February 28, 2018, we increased the conversion price of some of the related party convertible notes, which resulted in additional amortization expense of $346,472 during the nine months ended February 28, 2018. During the three months ended February 28, 2018, we also had amortization of deferred financing costs of $19,450.
Loss on Note Exchange
During the ninethree months ended February 28, 2018, we increased the conversion price of some of the related party convertible notes, which resulted in additional amortization expense of $346,472 during the nine months ended February 28, 2018. During the nine months ended February 28, 2018, we also had amortization of deferred financing costs of $22,569.
Loss on extinguishmentExtinguishment of debtDebt
During the ninethree months ended February 28, 2018,November 30, 2017, we recognized a loss on the extinguishment of debt in the amount of $989,032. This loss is related to the exchange of the 8% Note for our common stock. There was no comparable transaction during the ninethree months ended February 28, 2017.
Change in fair value of derivative liability
During the three months ended November 30, 2017, we incurred a loss on the revaluation of derivative liability of $68,140 related to the reset provisions contains in certain of our convertible notes. On June 1, 2018, we adopted ASU 2017-11 and reclassified the aggregate amount of $1,295,751, which is the fair value of the reset provisions embedded in previously issued convertible notes payable and certain warrants with embedded anti-dilutive provisions, from liability to equity. Upon adoption of ASU 2017-11, we were no longer required to treat reset (anti-dilution) provisions as derivative liabilities.
Net loss
For the reasons above, we hadincurred a net loss for the ninethree months ended February 28,November 30, 2018 of $5,592,341$2,699,243, which is an increase of $3,471,441,$173,645, or approximately 164%7%, compared to a net loss of $2,120,900$2,525,598 during the ninethree months ended February 28,November 30, 2017.
Results of Operations for the Six Months Ended November 30, 2018 and 2017
Revenues
We had revenues of $3,156,263 and $0 during the six months periods ended November 30, 2018 and November 30, 2017. The increase in revenue for the six months ended November 30, 2018 is due to our acquisition of the Oasis LLCs. Our cannabis dispensary accounted for $2,159,622 of our revenue, and our cannabis production accounted for $996,641 of our revenue.
Cost of goods sold
Our cost of goods sold for the six months ended November 30, 2018 was $1,806,611, compared to cost of goods sold of $0 for the six months ended November 30, 2017. The increase in cost of goods sold for the six months ended November 30 2018 is due to our acquisition of the Oasis LLCs. Cost of goods sold consisted of $1,754,897 of product cost, $43,277 of licensing fees, $5,373 of supplies and materials, and $3,064 of freight. Our gross margin for the six months ended November 30, 2018 was 43%.
Selling, general and administrative expenses
Selling, general and administrative expenses increased $17,752,583, or approximately 2,879%, to $18,369,166 during the six months ended November 30, 2018, compared to $616,583 for the six months ended November 30, 2017. The increase in selling, general and administrative expenses for the six months ended November 30, 2018 was primarily due to one-time financing and acquisition costs attributable to the acquisition of the Oasis LLCs, as well as ongoing operational costs of the Oasis LLCs. The one-time financing and acquisition costs consisted primarily of: the fair value of the special warrants and compensation broker warrants issued to Canaccord in connection with our sale of the special warrants in the amount of $2,908,673; the fair value of additional warrants and special warrants issued due to the failure to meet certain registration statement filing requirements in connection with the Westpark offering and the Canaccord offering in the amount of $8,084,522; the fair value of 700,000 shares of common stock issued to Star Associates, which is affiliated with one of our directors, for services in connection with the Oasis transaction of $490,000; broker and agent fees and commission in the amount of $1,060,773, and a foreign exchange loss on conversion of the Canaccord funds from Canadian to U.S. dollars in the amount of $403,588.
The increase in selling, general, and administrative costs was also attributable to the costs associated with operating the Oasis LLCs, which we acquired effective June 27, 2018. The following increases in selling, general, and administrative expenses were associated entirely with the Oasis LLCs: office and facilities expense increased by $157,993, to $297,967; depreciation and amortization increased by $126,493, to $126,493; and insurance costs increased by $90,478, to $90,478. The following increases in selling, general, and administrative expenses were attributable partially to the Oasis LLCs and partially to the ongoing implementation of other aspects of our business plan and general corporate purposes: professional fees increased by $1,863,558, to $2,181,772, primarily in connection with costs associated with the 2018 U.S. Convertible Debenture offering and the 2018 Convertible Debenture offering related to our future proposed acquisitions and expansions plans; payroll and related costs increased by $997,131 to $1,131,694, of which $1,043,159 was attributable to Oasis; sales, marketing, and advertising costs increased by $747,992 to 753,240, of which $226,560 was directly attributable to Oasis; stock based compensation increased by $278,388, to 278,388, of which $227,709 was directly attributable to Oasis; travel costs increased by $147,383, to $166,019; and taxes and licenses increased by $129,702, to $129,702, which was directly attributable to Oasis. Although we expect expenses related to fundraising activities to vary depending on our future growth, we expect general and administrative expenses to increase in future periods as we implement our business plan and commence operations.
Interest expense
Interest expense for the six months ended November 30, 2018 was $2,336,669, an increase of $1,454,838, or 165%, compared to $881,831 for the six months ended November 30, 2017. We have recorded discounts on certain of our convertible debt due to beneficial conversion features. Interest expense in connection with the amortization of these discounts increased by $1,571,473 to $2,144,329 during the second half of fiscal 2018, compared to $572,856 in the comparable period of fiscal 2017 primarily due to a restructuring of certain notes payable during the first quarter of fiscal 2018. Also, during the six months ended November 30 2018, accrued interest on notes payable increased by $198,651 to $211,248 compared to $12,297 in the comparable period of fiscal 2017. This increase was the result on an increase in the principal amount of notes payable from $1,604,837 at November 30, 2017 to $10,772,909 at November 30, 2018. The increase in interest expense was partially offset by a decrease in interest expense on related party debt for the six months ended November 30, 2018 from $47,580 to $5,211, compared to $52,791 in the comparable period of the prior year as a result of a decrease in the principal amount of related party notes payable.
Gain on Settlement of Debt
During the six months ended November 30, 2017, we recognized a gain on the settlement of accounts payable in the amount of $3,480 because we repaid an account using our common stock. There was no comparable transaction during the six months ended November 30, 2018.
Loss on Modification of Debt
During the six months ended November 30, 2017, we recognized a loss on modification of debt in the amount of $29,145 related to the amendment of the 8% Note. There was no comparable transaction during the six months ended November 30, 2018.
Loss on Note Exchange
During the six months ended November 30, 2017, we recognized a loss on the exchange of debt in the amount of $404,532. This loss related to the exchange of the April 2015 Note for our common stock. There was no comparable transaction during the comparable period of fiscal 2017.
Loss on Extinguishment of Debt
During the six months ended November 30, 2017, we recognized a loss on the extinguishment of debt in the amount of $989,032. This loss is related to the exchange of the 8% Note for our common stock. There was no comparable transaction during the six months ended November 30, 2018.
Change in fair value of derivative liability
During the six months ended November 30, 2017, we incurred a loss on the revaluation of derivative liability of $174,090 related to reset provisions contained in certain of our convertible notes. On June 1, 2018, we adopted ASU 2017-11 and reclassified the aggregate amount of $1,295,751, which is the fair value of the reset provisions embedded in previously issued convertible notes payable and certain warrants with embedded anti-dilutive provisions, from liability to equity. Upon adoption of ASU 2017-11, we were no longer required to treat reset (anti-dilution) provisions as derivative liabilities.
Net loss
For the reasons above, we incurred a net loss for the six months ended November 30, 2018 of $19,356,183, which is an increase of $16,264,900, or approximately 526%, compared to a net loss of $3,091,283 during the six months ended November 30, 2017.
Liquidity and Capital Resources
The following table summarizes our total current assets, liabilities and working capital at February 28,November 30, 2018 compared to May 31, 2017.
February 28, 2018 | May 31, 2017 | |||||||
Current Assets | $ | 58,762 | $ | 79,720 | ||||
Current Liabilities | $ | 2,794,538 | $ | 1,826,478 | ||||
Working Capital (Deficit) | $ | (2,735,776 | ) | $ | (1,746,758 | ) |
November 30, 2018 | May 31, 2018 | |||||||
Current Assets | $ | 5,998,395 | $ | 54,374 | ||||
Current Liabilities | $ | 6,742,553 | $ | 2,689,148 | ||||
Working Capital (Deficit) | $ | (744,158 | ) | $ | (2,634,774 | ) |
At February 28,November 30, 2018, and May 31, 2017, we had a working capital deficit of $2,735,776 and $1,746,758, respectively. This$744,158, an increase of $1,890,616 from the working capital deficit occurred primarily becauseof ($2,634,774) we have not yet commenced earning revenues. We plan to commence earning revenues uponhad at May 31, 2018. Our working capital at November 30, 2018, includes $4,872,048 of cash. The increase in working capital was a result of our successful financing activities during the closing on our pending Acquisition Agreement with Alternative Solutions, which we believe will close in approximately May l, 2018, assuming certain conditions are satisfied, as described below. During the ninesix months ended February 28,November 30, 2018, we obtained loans from our officers, directors and entities affiliated with Frank Koretsky, one of our directors, to cover operating expenses. We also obtained a loan from FirstFire to pay the initial deposit due under the Acquisition Agreement. We obtained the funds for the second $1.8 million deposit from the proceeds of the Darling Capital loan and from the netincluding $15,535,978 in proceeds from the first closingsale of equity, $6,357,000 from the WestPark Offering. Thisissuance of convertible notes, and $158,615 from the issuance of related party notes. We are presently seeking to expand the Oasis Cannabis and related City Trees businesses in Nevada and are considering other potential acquisitions, including our previously announced potential acquisitions in Massachusetts. Our working capital deficitneeds will likely continue to increase, which could result in future working capital deficits, until we begin earning revenues but should not be viewed as an indicatorcomplete at least the first phase of our future performance once we commence earning revenues.expansion plan at Oasis Cannabis. We have operated at a loss since inception.
Cash flows used in operating activities was $909,072$5,757,327 during the ninesix months ended February 28,November 30, 2018 compared to $899,291$424,750 during the ninesix months ended February 28,November 30, 2017, an increase of $5,332,577 or 1,255%. The increase was primarily due to a net loss of $19,356,188, which was offset by approximately $11,396,783 of cash offering costs in connection with our fundraising activities; $768,388 of non-cash compensation; $2,144,333 of amortization of debt discounts, $539 of imputed interest; $12,659 of expense from a derivative triggering event and a change in the amountcomponents of $9,781. This increase is due primarily to annet working capital of $854,039. The increase in accounts payable and accrued expensescash used in operating activities is also related to the acquisition of the Oasis LLCs, which operated at February 28, 2018a loss. We expect cash flows used in operating activities to improve in the amount of $800,196 compared tonext twelve months as the prior period.
Cash flows used in investing activities was $2,050,000$11,017,805 during the ninesix months ended February 28,November 30, 2018 compared to $35,013$0 during the ninesix months ended February 28,November 30, 2017. The amounts used during the ninesix months ended February 28,November 30, 2018 were the initial $250,000 and $1,800,000 deposits made pursuant to the termsconsisted of the Acquisition Agreement. The amounts used duringcash payment of $5,982,710, net of cash acquired of $14,612, in connection with our acquisition of the nine months ended February 28, 2017 relatedOasis LLCs; and our loan to constructionIn Good Health in progress at our Colorado processing facility,the amount of $5,000,000 which has been put on hold.was made in connection with the grant of the option to us to acquire this entity.
Cash flows provided by financing activities provided $2,903,495was $21,594,216 during the ninesix months ended February 28,November 30, 2018 compared to $852,000$605,629 during the ninesix months ended February 28,November 30, 2017. The increase in cash flows fromprovided by financing activities during the ninesix months ended February 28,November 30, 2018 was primarily due to our salereceipt of the convertible notes to Darling, Efrat and David Lamadrid and the sale of our equity securities in the WestPark Offering.
Third Party Debt
The table below summarizes the status of our third party debt and reflects whether such debt remains outstanding, has been repaid, or has been converted into or exchanged for our common stock:
Name of Note | Original Principal Amount | Payment Details | |||||
April 2015 Note | $ | 200,000 | Repaid | Repaid in part and exchanged in part | |||
Old Main 8% Note | $ | 200,000 | Repaid | Exchanged for 4,500,000 shares | |||
FirstFire Note | $ | 363,000 | Repaid | Repaid | |||
Darling Capital Note | $ | 550,000 | Repaid | Converted into 1,808,000 shares | |||
Efrat Investments Note | $ | 55,000 | Repaid | Converted into 183,040 shares | |||
Todd Blatt | $ | 210,000 | Repaid | Repaid | |||
AJG Group | $ | 100,000 | Repaid | Repaid | |||
YA II PN Note | $ | 1,250,000 | Outstanding | Repayment commences December 2018 | |||
Oasis Note | $ | 4,000,000 | Outstanding | Due December 2019 | |||
2018 U.S. Convertible Debentures | $ | 5,857,000 | Outstanding | Due October 26-31, 2021 |
April 2015 Note
On April 29, 2015, we issued a convertible promissory note (the "April 2015 Note") to an unaffiliated individual in the amount of $200,000. Interest accrued on the April 2015 Note at a rate of 15% per annum. On the first anniversary of the April 2015 Note, all then-accrued interest was due thereunder. Thereafter, principal together with accrued interest was due in eight (8) equal quarterly payments, in arrears, commencing on July 1, 2016. All outstanding principal and any accumulated unpaid interest thereon was due and payable on the third anniversary of note. At the holder's election, at any time prior to payment or prepayment of the April 2015 Note in full, all principal and accrued interest under the April 2015 Note could be converted in whole, but not in part, into our securities. For each dollar converted, the holder would receive two shares of common stock and a three-year warrant to purchase 1.33 shares of common stock at $0.75 per share. During the year ended May 31, 2017, we repaid principal in the amount of $100,000 and interest in the amount of $53,837 on this note.
On September 20, 2017, we entered into an exchange agreement, whereby we agreed to exchange the April 2015 Note for 1,500,000 shares of our common stock. The holder of the April 2015 Note had previously sold it for $105,219, which represented the balance due by us, to StarForce Media, Inc., an entity that is not affiliated with us. We recognized a loss on this exchange in the amount of $404,082, which was charged to operations during the ninetwelve months ended February 28,May 31, 2018.
Old Main Agreements
On March 18, 2016, we issued Old Main an 8% Convertible Promissory Note (the “8% Note”) in the principal amount of $200,000 for Old Main’s commitment to enter into an equity line transaction with us and prepare all of the related transaction documents. The 8% Note bearsbore interest at the rate of 8% per annum. On October 6, 2016, we amended the 8% Note, among other documents (the “First Amendment”) to defer the commencement of amortization payments on the 8% Note so that they commenced at the earlier of February 3, 2017 or on the date the registration statement with respect to the underlying shares had been declared effective by the SEC. On such date, we were required to begin to redeem 1/6th of the face amount of the 8% Note and any accrued but unpaid interest on a monthly basis. Such amortization payment could be made, at our option, in cash or, subject to certain conditions, in our common stock pursuant to a conversion rate equal to the lower of (a) $1.07 (the “8% Note Fixed Conversion Price”) or (b) 75% of the lowest VWAP in the twenty (20) consecutive trading days ending on the trading day that is immediately prior to the applicable conversion date. Subject to certain exclusions, if we had sold or issued our common stock or certain common stock equivalents at an effective price per share that was lower than the 8% Note Fixed Conversion Price, the conversion price would have been reduced to equal to such lower price.
On November 28, 2016, we entered into a Second Amendment to the 8% Note issued on March 18 (the “Second Amendment”) to amend the 8% Note, among other documents, as amended by the First Amendment, in certain respects. Pursuant to the Second Amendment, among other things, the 8% Note was converted from an installment note to a “balloon” note, with all principal and interest on the 8% Note due on March 18, 2017; the Fixed Conversion Price associated with the 8% Note was changed to a variable conversion price equal to the lesser of the prior Fixed Conversion Price or 75% of the lowest VWAP in the fifteen trading days ending on the trading day immediately prior to the conversion date; our ability to repay the 8% Note with our common stock was deleted except pursuant to a voluntary conversion by Old Main; and Old Main was prohibited from selling, per trading day, an amount of our common stock in excess of the greater of $5,000 or 25% of the average number of shares of common stock sold per day for the five trading days preceding the day of sale multiplied by the average daily VWAP during the immediately preceding 5-trading day period.
On March 27, 2017, we entered into the third amendment to the 8% Note, which, among other things, increased the outstanding amount due under the 8% Note as of March 18, 2017 by 5%. In exchange for doing so, Old Main agreed to extend the maturity of the 8% Note until July 1, 2017 and to suspend conversions under the 8% Note until July 1, 2017.
On July 6, 2017, we entered into the fourth amendment to the 8% Note (the “Fourth Amendment”) to further amend the terms of the 8% Note. Pursuant to the Fourth Amendment, the maturity date of the 8% Note was extended to July 15, 2017 and the outstanding balance of the 8% Note as of June 30, 2017 was increased by multiplying it by 1.075. The Fourth Amendment was effective on June 30, 2017.
On August 23, 2017, we entered into the fifth amendment to the 8% Note (the “Fifth Amendment”) to further amend the terms of the 8% Note. Pursuant to the Fifth Amendment, the maturity date of the 8% Note was extended to September 15, 2017 and the outstanding balance remained unchanged. The Fifth Amendment was effective on July 15, 2017.
On September 25, 2017, but effective as of September 15, 2017, we entered into an Exchange Agreement,exchange agreement, whereby we agreed to exchange the 8% Note for 4,500,000 shares of our common stock. Pursuant to an oral agreement with the original holder of the 8% Note, principal due under the 8% note was increased by $96,862 to a total of $322,612 prior to the date on which the exchange of the 8% Note for common stock occurred.
On April 18, 2016, we also entered into an equity line agreement with Old Main whereby we may issue and sell to Old Main, at our option from time to time, up to $4,000,000 of our common stock at a purchase price equal to 80% of the lowest VWAP of the common stock during a five day “Valuation Period.”
On October 6, 2016, we entered into an amendment to the equity line Agreement to amend the new commitment period, which is 24 months from the date of this amendment. Second, the equity line agreement was amended to prohibit us from delivering a subsequent put notice from the beginning of any “Valuation Period” until the fourth trading day immediately following the closing associated with the prior put notice. Third, the beneficial ownership limitation was amended to increase the beneficial ownership limitation to 9.99% and to remove the ability of Old Main to increase or decrease the beneficial ownership limitation.
FirstFire Note
On November 15, 2017, we entered into a Securities Purchase Agreement (the “Purchase Agreement”)securities purchase agreement with FirstFire Global Opportunities Fund, LLC (“FirstFire”), whereby FirstFire agreed to purchase a 5% Senior Convertible Promissory Notesenior convertible promissory note in the aggregate principal amount of $363,000 (the “FirstFire Note”) from us due, subject to the terms therein, due seven (7) months from the date of issuance, for a purchase price of $330,000.
The FirstFire Note bearsbore interest at the rate of 5% per annum. Any past due accrued and unpaid interest to be paid under the FirstFire Note bearswas to bear interest at the lesser of 15% per annum or the maximum rate permitted by applicable law. At any time prior to the 180th day following the date of issuance, we maycould prepay all or any portion of the principal amount of the FirstFire Note and any accrued and unpaid interest by paying the following amounts: (i) within the initial 90 days after the date of issuance: 115% multiplied by the principal amount then due plus accrued interest; and (ii) from the 91st day through the 180th day after the date of issuance: 125% multiplied by the principal amount then due plus accrued interest.
The FirstFire Note iswas convertible at any time into shares of our common stock, at the option of the holder, at an initial conversion rate equal $0.40 per share of common stock (the “Fixed Conversion Price”). Any time on or after the 180th day after the issuance of the FirstFire Note, the conversion price shallwould equal the lower of (a) the Fixed Conversion Price or (b) 75% of the lowest traded price of our common stock in the 20 consecutive trading days immediately prior to the day that we receive the applicable conversion notice. Subject to certain exclusions, if we sell or issue our common stock or certain common stock equivalents at an effective price per share that is lower than the then applicable conversion price, the conversion price will be reduced to be equal to such lower price. In the event of any event of default under the FirstFire Note, the outstanding principal amount of the FirstFire Note plus accrued but unpaid interest, multiplied by 150%, shall become immediately due and payable in common stock and/or cash, at the election of the holder.
On the closing date, we also issued FirstFire a three yearthree-year common stock purchase warrant to purchase 350,000 shares of our common stock at an initial exercise price of $0.75 per share and agreed to issue FirstFire promptly following the closing date 250,000 shares of our restricted common stock as a commitment fee to enter into the Purchase Agreementpurchase agreement and prepare all of the related transaction documents.
On May 9, 2018, we entered into an amendment to the FirstFire Note, whereby we agreed to make a $50,000 payment on or before May 14, 2018 and a $450,000 payment on or before May 31, 2018 to repay the FirstFire Note in full. We also agreed to issue an additional warrant to purchase 25,000 shares of our common stock. In exchange, the note holder agreed that it would not convert the FirstFire Note until after May 31, 2018. During the twelve months ended May 31, 2018, we made payments of $500,000 on this note, which amounts repaid the FirstFire Note in full.
Darling Capital Note
On February 5, 2018, we entered into a Securities Purchase Agreementsecurities purchase agreement with Darling Capital LLC, (“Darling”), whereby Darling agreed to purchase a 8% Convertible Promissory Noteconvertible promissory note in the aggregate principal amount of $550,000 (the “Darling Note”) from us due, subject to the terms therein, eighteen (18) months from the date of issuance, for a purchase price of $500,000.
Darling may,could, at its option, convert all or a portion of the Darling Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Darling Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Darling Note will be reset to such lower price.
On June 12, 2018, we received a conversion notice from Darling notifying us that it had converted $550,000 in principal and $15,000 of accrued interest into 1,808,000 shares of our common stock.
Efrat Investments Note
On February 16, 2018, we entered into a Securities Purchase Agreementsecurities purchase agreement with Efrat Investments LLC, (“Efrat”), whereby Efrat agreed to purchase a 8% Convertible Promissory Noteconvertible promissory note in the aggregate principal amount of $55,000 (the “Efrat Note”) from us due, subject to the terms therein, eighteen (18) months from the date of issuance, for a purchase price of $50,000.
Efrat may,could, at its option, convert all or a portion of the Efrat Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Efrat Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Efrat Note will be reset to such lower price.
On August 9, 2018, we received a conversion notice from Efrat notifying us that it had converted $55,000 in principal and $2,200 of accrued interest into 183,040 shares of our common stock.
The YA II PN, Ltd. Notes
On May 11, 2018, we entered into a securities purchase agreement with YA II PN, Ltd. (“YA II”), pursuant to which we agreed to sell to YA II, in two closings, (i) convertible debentures in the aggregate principal amount of $1,250,000, plus accrued interest, which may be converted into shares of our common stock, at the discretion of either YA II or us in accordance with the terms of the debentures, and (ii) five-year warrants to purchase an aggregate of 3,125,000 shares of our common stock at $0.60 per share of common stock. At the first closing, which occurred on May 14, 2018, we issued a $750,000 debenture to YA II and warrants to purchase 1,875,000 shares of our common stock. At the second closing, which occurred on July 20, 2018, we issued a $500,000 debenture to YA II and warrants to purchase 1,250,000 additional shares of our common stock.
The debentures bear interest at the rate of 8% per annum. If an event of default occurs and for so long as such event of default remains uncured, the interest rate on the debentures shall immediately become 15% per annum and shall remain at such increased interest rate until the applicable event of default is cured.
Commencing on December 1, 2018 and on the first day of each month thereafter through July 1, 2019 (each an “Installment Date”), subject to certain exceptions, we shall pay to YA II one-eighth of the principal amount of the debentures, plus accrued and outstanding interest (the “Installment Amount”), plus 20% of the of the Installment Amount for Installment Amounts due within 180 days following the date of execution of the purchase agreement, and 25% of the Installment Amount for Installment Amounts due thereafter in cash or by converting such Installment Amount into shares of our common stock. if we have met the applicable conditions for such a conversion and as long as the conversion does not exceed certain maximum amounts.
Pursuant to the terms of the debentures, YA II may elect to convert any portion of the principal and accrued interest under the debentures into our common stock at a fixed conversion price of $0.40 per share. The fixed conversion price may change if certain dilutive events or issuances occur. In addition, we may, at our sole discretion, make an Installment Payment using our common stock if certain conditions have been met. In such case, the applicable conversion price would be equal to 75% of the VWAP of our common stock during the fifteen consecutive trading days immediately preceding such conversion. During the three months ended August 31, 2018, a reset event occurred. As a result, the conversion price of the first YA II PN Note, in the principal amount of $750,000, was reduced to $0.34 per share of common stock.
During the six months ended November 30, 2018, YA II converted a total of $280,247, which consisted of $250,000 of principal and $30,247 of accrued interest, into 700,616 shares of common stock. On January 8, 2019, YA II converted $256,027, of which $250,000 was principal and $6,027 was accrued interest, into 640,068 share of common stock.
Blatt Note
On February 7, 2018, we issued a note payable to Todd Blatt in the amount of $210,000. This note accrued interest at a rate of 6% per annum and was due on February 7, 2019. This note along with $5,627 of accrued interest was paid on July 20, 2018.
AJG Group Note
On February 7, 2018, we issued a note payable to AJG Group in the amount of $200,000. This note accrued interest at a rate of 6% per annum and was due on February 7, 2019. We made a principal payment in the amount of $100,000 on this note on March 30, 2018; we then made an additional principal payment of $100,000, together with accrued interest in the amount of $3,337, on July 9, 2018.
Oasis Note
On June 27, 2018, we closed on the purchase of the remaining 90% of the membership interests of Alternative Solutions and the Oasis LLCs. The closing occurred pursuant to the Acquisition Agreement dated December 4, 2017, as amended. On such date, we made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (the “Oasis Note”), and 22,058,823 shares of its common stock. The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because we assumed an additional $204,457 of liabilities. The Oasis Note bears interest at the rate of 6% per annum. The Oasis Note may be prepaid at any time without penalty. The Oasis Note is secured by all of the membership interests in Alternative Solutions and the Oasis LLCs and by the assets of the Oasis LLCs.
2018 U.S. Convertible Debenture Offering
Between October 25, 2018 and November 2, 2018, we entered into six subscription agreements pursuant to which we agreed to sell, for an aggregate purchase price of $5,857,000, $5,857,000 in original principal amount of convertible debentures in minimum denominations of $1,000 each. The debentures bear interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen (18) months following their issuance, being payable by increasing the then-outstanding principal amount of the debentures. The debentures mature on a date that is three years following their issuance. The debentures are convertible into units at a conversion price of $0.80 per unit. Each unit consists of (i) one share of our common stock; and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share at a price of $1.10. The debentures have other features, such as mandatory conversion in the event the shares trade at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The debentures are unsecured obligations of the Company and rank pari passu in right of payment of principal and interest with all other unsecured obligations of the Company. Navy Capital and its affiliates purchased $5,000,000 in principal amount of debentures, with the remaining $857,000 in principal amount being purchased by several unaffiliated purchasers.
If the debentures are converted, the warrants that would be issued are exercisable from time to time, in whole or in part for three years. The warrants have anti-dilution provisions that provide for an adjustment to the exercise price in the event of a future sale of common stock at a lower price, subject to certain exceptions as set forth in the warrant. The warrants also provide that we can force their exercise at any time after the bid price of the common stock exceeds $2.20 for a period of 20 consecutive business days.
Related Party Debt
David Lamadrid Note
On February 26, 2018, we entered into a Securities Purchase Agreementsecurities purchase agreement with David Lamadrid, (“Lamadrid”), our former President and Chief Financial Officer, whereby Mr. Lamadrid agreed to purchase a 8% Convertible Promissory Note in the aggregate principal amount of $31,250 (the “Lamadrid Note”) from us due, subject to the terms therein, eighteen (18) months from the date of issuance.
Mr. Lamadrid may,could, at his option, convert all or a portion of the Lamadrid Note and accrued but unpaid interest into shares of common stock at a conversion price of $0.3125 per share. The Lamadrid Note also contains a reset feature, whereby, absent certain exceptions, if the Company issues equity securities at an effective price less than $0.3125 per share of common stock, the conversion price of the Lamadrid Note will be reset to such lower price.
On August 21, 2018, we received a conversion notice from Mr. Lamadrid notifying us that he had converted $31,250 in principal and $1,247 of accrued interest into 103,989 shares of our common stock.
Koretsky and Affiliate Notes
Between August 11, 2015 and May 31, 2017, we borrowed an aggregate of $1,657,000 from Frank Koretsky, a director of the Company, and $150,000 from CLS CO 2016, LLC and $465,000 from Newcan Investment Partners, LLC, two entities that are affiliated with Mr. Koretsky. These loans were unsecured, accrued interest between 6% and 15% per year, were due either on demand or within three years after the date of the applicable note, and, in some cases, were convertible into shares of our common stock and warrants at rates between $.25$0.25 and 1.07 per share. Effective on May 31, 2017, we entered into the Omnibus Loan Amendment Agreement, whereby the portion of these loans that was advanced prior to December 31, 2017 was converted into our common stock, together with accrued interest on these loans. As a result of these conversions, Mr. Koretsky, CLS CO 2016 and Newcan converted an aggregate of $1,485,000, $150,000, and $460,000 in principal, and $130,069, 49,247 and $7,747 in accrued interest, into an aggregate of 6,460,276, 636,988 and 1,870,988 shares of common stock at $.25 per share. Pursuant to the Omnibus Loan Amendment Agreement, the conversion rate on all of the loans made by Mr. Koretsky, CO CLS 2016, and Newcan was reduced, if applicable, to $.25 per share and Mr. Koretsky and his affiliates gave up the right to receive warrants upon conversion. Thus, each of Mr. Koretsky, CLS CO 2016 and Newcan received 4,560,849, 488,159 and 1,433,841 shares of common stock in excess of what they would have received had they converted their loans into common stock prior to the effective date of the Omnibus Loan Amendment Agreement.
Between June 1, 2017 and May 31, 2017, $120,0002018, we borrowed an aggregate of $145,000 from Newcan Investment Partners, LLC, an entity that is affiliated with Mr. Koretsky. These loans were unsecured, accrued interest at 10% per year, were due either on demand or within three years after the date of the Koretsky Funding Notes was exchanged for Newcan Convertible Note 1. Thisapplicable note, is unsecured and bears interest at the ratewere convertible into shares of 10% per annum. No payments are required until April 1, 2018, at which time all accrued interest becomes due and payable. Principal will be payable in eight equal quarterly installments, together with accrued interest, beginning on July 1, 2018. At Newcan’s election, at any time prior to payment or prepayment of the loans in full, all principal and accrued interest under the loans may be converted, in whole or in part, into our common stock and warrants at the rate of one share for each $0.25 converted.
On August 6, 2018, we issued a convertible promissory note to Newcan, an entity owned by Frank Koretsky, a director of the Company, in the amount of $75,000.00 (the “Newcan Convertible Note 8”), to finalize the terms of repayment with respect to a certain loan made to the Company by Newcan on May 4, 2018. The Newcan Convertible Note 8 is unsecured and bears interest at the rate of 10% per annum. No payments are required until October 1, 2019, at which time all accrued interest becomes due and payable. Principal will be paid in eight equal quarterly installments, together with interest accrued thereon, beginning on January 1, 2020. The Notes may be prepaid by us with no penalty at any time upon thirty days written notice. The holder of the Newcan Convertible Note 9 may, at any time prior to payment or prepayment in full, convert all principal and accrued interest thereunder, in whole or in part, into securities of the Company. For each $0.40 converted, the holder will receive one share of our common stock.
During the six months ended November 30, 2018, Newcan converted a total of $78,534, which consisted of $75,000 of principal and $3,534 of accrued interest, into 196,336 shares of common stock.
Binder Notes
Between June 1, 2015 and May 31, 2017, we borrowed an aggregate of $251,800 from Jeffrey Binder, a director and officer of the Company. These loans were unsecured, accrued interest between 6% and 10% per year, were due either on demand or within three years after the date of the applicable note, and, in some cases, were convertible into shares of our common stock and warrants at rates between $.25 and 1.07 per share. Effective on May 31, 2017, we entered into the Omnibus Loan Amendment Agreement, whereby the portion of these loans that was advanced prior to May 31, 2017 was converted into our common stock, together with accrued interest on these loans. As a result of these conversions, Mr. Binder converted an aggregate of $442,750 in principal and $19,427 in accrued interest, into an aggregate of 1,848,708 shares of common stock at $.25 per share. Pursuant to the Omnibus Loan Amendment Agreement, the conversion rate on all of the loans made by Mr. Binder was reduced, if applicable, to $.25 per share and Mr. Binder gave up the right to receive warrants upon conversion. Thus, Mr. Binder received 1,127,061 shares of common stock in excess of what he would have received had he converted his loans into common stock prior to the effective date of the Omnibus Loan Amendment Agreement.
Between June 1, 2017 and March 31, 2017, $47,0002018, we borrowed an aggregate of $204,881 from Mr. Binder. These loans were unsecured, accrued interest at 10% per year, were due either on demand or within three years after the date of the Binder Funding Notesapplicable note, and $25,000were convertible into shares of accrued salary due to Mr. Binder were exchanged for Binder Convertible Note 4. This note is unsecured and bears interest at the rate of 10% per annum. No payments are required until April 1, 2018, at which time all accrued interest becomes due and payable. Principal will be payable in eight equal quarterly installments, together with accrued interest, beginning on July 1, 2018. At Mr. Binder’s election, at any time prior to payment or prepayment of the loans in full, all principal and accrued interest under the loans may be converted, in whole or in part, into our common stock and warrants at the rate of one share for each $0.25 converted.
On April 6, 2018, we issued Binder Convertible Note 8,9, in the amount of $37,500.00,$37,500, to Mr. Binder with respect to certain compensation payable to Mr. Binder as of February 28, 2018. Binder Convertible Note 8 is unsecured and bears interest at the rate of 10% per annum. No payments are required until April 1, 2019, at which time all accrued interest becomes due and payable. Principal will be paid in eight equal quarterly installments, together with interest accrued thereon, beginning on July 1, 2019. The note may be prepaid by us with no penalty at any time upon thirty days written notice. Mr. Binder may, at any time prior to payment or prepayment in full, convert all principal and accrued interest thereunder, in whole or in part, into our securities. For each $0.3125 converted, Mr. Binder will receive one share of the Company’sour common stock.
Omnibus Loan Amendment Agreement and Second Omnibus Loan Amendment
On May 31, 2017, we entered into an Omnibus Loan Amendment Agreement (the “Omnibus Loan Amendment”) with Jeffrey I. Binder, Frank Koretsky, Newcan Investment Partners LLC and CLS CO 2016, LLC (collectively, the “Insiders”). Pursuant to the Omnibus Loan Amendment, we agreed with the Insiders to amend certain terms of loans the Insiders made to us for working capital purposes, which loans were initially demand loans, and, except for certain loans made in 2017, were later memorialized as convertible loans (the “Insider Loans”), in exchange for the agreement of the Insiders to convert all Insider Loans where funds were advanced prior to January 1, 2017, which total $2,537,750, plus $166,490 of accrued interest thereon, into an aggregate of 10,816,960 shares of our common stock, and forego the issuance of warrants to purchase our common stock upon conversion. This resulted in the issuance of an additional 7,609,910 shares compared to the original number of shares issuable upon conversion of the Insider Loans prior to the Omnibus Loan Agreement. We valued the shares at $0.125, which was the market price of our stock at the conversion date, and charged the amount of $951,239 to loss on modification of debt during the twelve months ended May 31, 2017.
We entered into the Omnibus Loan Amendment in order to ease the debt burden on us and prevent us from defaulting on the Insider Loans. Pursuant to the Omnibus Loan Amendment, the following amendments were made to the Insider Loans: (a) we reduced the conversion price on the Insider Loans from between $0.75 and $1.07 per share of common stock to $0.25 per share of common stock, in those cases where the conversion price was greater than $0.25, which reduced conversion price exceeds the closing price of the common stock during the last three months; (b) we deleted the requirement to issue warrants to purchase our common stock upon conversion of the Insider Loans; (c) we amended one Insider Loan to permit conversion of only the portion of the Insider Loan related to services that were provided to us prior to January 1, 2017; and (d) we amended the terms of the Insider Loans where funds were advanced on or after January 1, 2017, which Insider Loans were not converted into our common stock, to provide for, where not already the case, a 10% interest rate per annum, a $0.25 conversion price per share of common stock, and the deletion of the requirement that we issue warrants to purchase our common stock upon conversion of such Insider Loans.
On January 10, 2018, effective December 1, 2017, we entered into the Second Omnibus Loan Agreement with Jeffrey I. Binder, an officer and director of the Company, and Newcan, an entity owned by Frank Koretsky, a director of the Company. The Second Omnibus Loan Agreement provides that the conversion price of all outstanding convertible promissory notes issued to either Mr. Binder or Newcan as of the date of the Agreementsuch agreement would be increased from $0.25 to $0.3125 per share of common stock. The remaining terms of such notes remain unchanged.
WestPark Offering
During February and March 2018, we held four closings of the WestPark Offering, whereby we sold units for $1.25 per unit. Each unit consisted of four shares of common stock and one warrant to purchase one share of our common stock for $0.75 per share. We sold a total of 1,368,250 units in the WestPark Offering for aggregate gross proceeds of $1,710,313, and aggregate net proceeds of $1,460,918 after deduction of placement agent commissions, a non-accountable expense allowance and expenses associated with the offering. We also issued WestPark Capital, Inc., as placement agent, a five-year warrant to purchase 205,238 units at a price of $1.25 per unit. The unit warrant were valued at $503,655, which amount was charged to operations during the twelve months ended May 31, 2018. We used the proceeds of the WestPark Offering towards deposits due in connection with our acquisition of Oasis Cannabis and for general corporate purposes. During the three months ended August 31, 2018, we issued 1,368,250 four-year warrants at an exercise price of $0.50 per share at a fair value of $941,972 to the investors in the Westpark Offering as a penalty for failure to timely file a registration statement with respect to the securities we sold to them in the Westpark Offering.
The Canaccord Special Warrant Offering
On June 20, 2018, we executed an agency agreement with Canaccord Genuity Corp. and closed on a private offering of our special warrants for aggregate gross proceeds of CD$13,037,859 (USD$9,785,978). In connection therewith, we also entered into a special warrant indenture and a warrant indenture with Odyssey Trust Company, as special warrant agent and warrant agent.
Pursuant to the offering, we issued 28,973,019 special warrants at a price of CD$0.45 (USA$0.34) per special warrant. Each special warrant was automatically exercisable, for no additional consideration, into our units on the earlier of: (i) the date that was five business days following the date on which we obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of our acquisition of all of the membership interests in Alternative Solutions, known as Oasis Cannabis, which occurred on June 27, 2018.
Upon exercise of the special warrants, each unit was to consist of one share of our common stock and one warrant to purchase one share of common stock. Each warrant was to be exercisable at a price of CD$0.65 for three years after our common stock was listed on a recognized Canadian stock exchange, subject to adjustment in certain events. Because we did not receive a receipt from the applicable Canadian securities authorities for the qualifying prospectus by August 19, 2018, each unexercised special warrant generally entitles the holder to receive 1.1 of our units instead of one unit.
On November 30, 2018, all of the special warrants were automatically exercised for an aggregate of 33,465,110 shares of common stock and warrants to purchase 33,465,110 shares of common stock for C$0.65 per share.
In connection with the offering, we paid a cash commission and other fees equal to CD$1,413,267 (USD$1,060,773), a corporate finance fee equal to 1,448,651 special warrants with a fair value of USD$1,413,300, and 2,317,842 compensation broker warrants with a fair value of USD$1,495,373. Each compensation broker warrant entitles the holder thereof to acquire one unit at a price of CD$0.45 per unit for a period of 36 months from the date that our common stock is listed on a recognized Canadian stock exchange, subject to adjustment in certain events. Our common stock commenced trading on the Canadian Stock Exchange on January 7, 2019. During the three months ended August 31, 2018, we also issued investors 3,042,167 special warrants with a fair value of $7,142,550 as a penalty for failure to timely effect a Canadian prospectus with regard to the securities underlying the special warrants.
We used the proceeds for the Canaccord offering to close the purchase of Oasis Cannabis and for general corporate purposes.
The Navy Capital Investors
Effective July 31, 2018, we entered into a subscription agreement with Navy Capital Green International, Ltd., a British Virgin Islands limited company (“Navy Capital”), pursuant to which we agreed to sell to Navy Capital, for a purchase price of $3,000,000, 7,500,000 Units ($0.40 per unit), representing (i) 7,500,000 shares of our common stock, and (ii) three-year warrants to purchase an aggregate of 7,500,000 shares of our common stock (the “Warrant Shares”) at an exercise price of $0.60 per share of common stock. The closing occurred on August 6, 2018. In the subscription agreement, we also agreed to file, on or before November 1, 2018, a registration statement with the SEC registering the shares of common stock and Warrant Shares issued to Navy Capital. If we fail to file the registration statement on or before that date, we must issue to Navy Capital an additional number of units equal to ten percent (10%) of the units originally subscribed for by Navy Capital (which will include additional warrants at the original exercise price). The warrant is exercisable from time to time, in whole or in part for three years. The warrant has anti-dilution provisions that provide for an adjustment to the exercise price in the event of a future sale of common stock at a lower price, subject to certain exceptions as set forth in the warrant. The warrant also provides that it is callable at any time after the bid price of our common stock exceeds 120% of the exercise price of the warrant for a period of 20 consecutive business days.
Between August 8, 2018 and August 10, 2018, we entered into five subscription agreements, pursuant to which we sold, for an aggregate purchase price of $2,750,000, 6,875,000 Units ($0.40 per unit), representing (i) 6,875,000 shares of our common stock, and (ii) three-year warrants to purchase an aggregate of 6,875,000 shares of our common stock at an exercise price of $0.60 per share of common stock. The balance of the terms set forth in the subscription agreements are the same as the terms in the Navy Capital subscription agreement summarized above.
We plan to use the proceeds of the Navy Capital offering to fund certain planned expansions at our City Trees and Oasis Cannabis businesses in Nevada and for general corporate purposes.
Liquidity and Capital Needs
Over the next twelve months we will likely require significant additional capital to cover our projected cash flow deficits, due to payments on the loan from FirstFire,YA PN II, the implementation of our business plan, including the acquisitionexpansion of Oasis Cannabis,our Nevada operation, and the development of other alternative revenue sources.
During the next twelve months we expect to complete phase 1 and possibly phase 2 of our expansion plan, which includes the substantial expansion of our grow facility in Nevada. At present, we estimate that we will require up to $3,000,000 to complete phase 1 and up to $2,000,000 to complete phase 2 of this expansion (excluding development of the outdoor space). We currently have two employees, Jeffrey Binder, who serves as our Chairman and Chief Executive Officer, and David Lamadrid, who serves as our President and Chief Financial Officer. In an effort to assist us conserve cash, Mr. Binder converted all his accrued salary due to him through February 28, 2018 into convertible promissory notes. Mr. Bonsett, our former Chief Operating Officer, left the Company effective October 1, 2017.
Although our revenues are expected to grow as we expand our operations, our revenues are not expected to exceed operating costs until approximately the first quarter of our equity securities or for additional loans and although2019. Although we believe we have entered into a definitive agreementsufficient funds to acquire Oasis Cannabis,sustain our operations at their current level until such time, if we require additional cash, we expect to obtain the necessary funds as described below,above; however, our prospects must be considered in light of the closingrisks, expenses and difficulties frequently encountered by companies in their early stage of such agreement is subject to numerous conditions,operations. To address these risks, we must, among other things, seek growth opportunities through additional debt and/or equity investments and acquisitions in our industry, successfully execute our business strategy, including our abilityplanned expansion and acquisitions, and successfully navigate any changes that may arise in the cannabis regulatory environment. We cannot assure that we will be successful in addressing such risks, and the failure to raise the required cash. Becausedo so could have a material adverse effect on our business prospects, financial condition and results of operations.
Although PRH made one payment to us during fiscal 2018, because we do not know when we will re-visit commencing operations in Colorado, there can be no assurance that PRH will ever generate sufficient cash to repay the $500,000 loan from CLS Labs Colorado or to meet PRH’s obligations under the Licensing Agreement or Equipment Lease. Further, due to the delays we encountered with the construction of our Colorado processing facility, we have placed our proposed Colorado operations on hold and will pursue revenue producing opportunities in other states. We anticipate that we may incur operating losses during the next twelve months unless we close on the Oasis Acquisition.
Oasis Cannabis Transaction
On December 4, 2017, CLS Holdings USA, Inc. (the “Company,” “CLS” or “we”) and Alternative Solutions, LLC (“Alternative Solutions”)we entered into a Membership Interest Purchase Agreement, as amended (the “Acquisition Agreement”“Acquisition Agreement”), as amended, with Alternative Solutions for CLSus to acquire (the “Oasis Acquisition”)all of the outstanding equity interests in three subsidiaries of Alternative Solutions (collectively,and the “Oasis LLCs”).LLCs. Pursuant to the Acquisition Agreement, CLSwe paid a non-refundable deposit of $250,000 upon signing, which was to be followed by an additional payment of $1,800,000 withinapproximately 45 days (75 days if an extension feethereafter and were to receive, upon receipt of $200,000 is paid by CLS) forapplicable regulatory approvals, an initial 10% of each of the Oasis LLCs.
On January 16,June 27, 2018, CLS and Alternative Solutions entered into a First Amendment towe closed on the Membership Interest Purchase Agreement (the “First Amendment”) and extended the date upon which the $1,800,000 is to be paid to January 29, 2018 at 5:00 p.m. PST.
The number of Purchase Price Shares shall equalshares to be issued was computed as follows: $6,000,000 divided by the lower of $1.00 or the conversion price to receive one share of our common stock in our nextfirst equity offering of a certain minimum size that commencescommenced in 2018, multiplied by 80%. This price was determined to be $0.272 per share. The Oasis Note will beis secured by a first priority security interest over our membership interests in Alternative Solutions and the Oasis LLCs, and by the assets of each of the Oasis LLCs and Alternative Solutions, including our 10% equity interest in the Oasis LLCs, and CLS shall deliver to Alternative SolutionsSolutions. We also delivered a confession of judgment to a representative of the former owners of Alternative Solutions and the Oasis LLCs (other than Alternative Solutions) that will generally become effective in the event of any event of default under the Oasis Note.
Oasis currently owes certain amounts to a consultant known as 4Front Advisors, LLC. If we make any payments to this company post-closing, generally speaking, we will be entitled to deduct the present value of such payments from the principal amount due under the Oasis Note.
In May 2020, the former owners of Alternative Solutions and the Oasis LLCs (other than Alternative Solutions) will also be entitled to a $1,000,000 payment from us (the “Bonus Purchase Price”) if the existing dispensary operated by an Oasis LLC has maintained an average revenue of $20,000 per day during the 2019 calendar year.
The sale, assignment, transfer pledge or other disposition of any interest90% of the membership interests in Alternative Solutions and the Oasis LLCs or Alternative Solutions is ineffective unlessto us was approved in advance by the stateState of Nevada and any municipalityon December 12, 2018.
Consulting Agreements
On July 24, 2018, we issued 700,000 shares of common stock with a fair value of $490,000 to Star Associates for services in which the Oasis LLC’s operation is licensed.
Going concern
Our financial statements were prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. We have incurred continuous losses from operations since inception, have an accumulated deficit of $14,583,951$37,925,277 and had a working capital deficit of $2,735,776$744,158 at February 28,November 30, 2018. In addition, we do not currently haveThe report of our independent auditors for the cash resources to meet our operating commitments during the next twelve months.year ended May 31, 2018, contained a going concern qualification. Our ability to continue as a going concern must be considered in light of the problems, expenses, and complications frequently encountered by developmentalearly stage companies.
Our ability to continue as a going concern is dependent on our ability to generate sufficient cash from operations to meet our cash needs, to borrow capital and to sell equity to support our plans to acquire operating businesses, open processing facilities and finance ongoing operations. There can be no assurance, however, that we will be successful in our efforts to raise additional debt or equity capital and/or that cash generated by our future operations will be adequate to meet our needs. These factors, among others, indicate that we may be unable to continue as a going concern for a reasonable period of time.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Management uses various estimates and assumptions in preparing our financial statements in accordance with generally accepted accounting principles. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Accounting estimates that are the most important to the presentation of our results of operations and financial condition, and which require the greatest use of judgment by management, are designated as our critical accounting estimates. We have the following critical accounting estimates:
● | Estimates and assumptions used in the valuation of derivative liabilities: Management utilizes a lattice model to estimate the fair value of derivative liabilities. The model includes subjective assumptions that can materially affect the fair value estimates. |
Recently Issued Accounting Standards
Accounting standards promulgated by the Financial Accounting Standards Board (“FASB”) are subject to change. Changes in such standards may have an impact on our future financial statements. The following are a summary of recent accounting developments.
In August 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-15, Statement of Cash Flows (Topic 230). The update addresses eight specific cash flow issues and is intended to reduce diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update will bewas effective for reporting periods beginning after December 15, 2017, including interim periods within the reporting period. Early adoption is permitted. We are currently evaluatingdo not believe that the potentialimplementation of this update has had a material impact of the update on our financial statements.
In January 2017, the FASB issued ASU No. 2017-04,
Simplifying the Test for Goodwill Impairment, which simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, current U.S. GAAP requires the performance of procedures to determine the fair value at the impairment testing date of assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, the amendments under this ASU require the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The ASU becomes effective for us on January 1, 2020. The amendments in this ASU will be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed.In May 2017, the FASB issued ASU No. 2017-09,
Stock Compensation - Scope of Modification Accounting, which provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The ASU requires that an entity account for the effects of a modification unless the fair value (or calculated value or intrinsic value, if used), vesting conditions and classification (as equity or liability) of the modified award are all the same as for the original award immediately before the modification. The ASUEffective June 1, 2018, we adopted Accounting Standards Codification (“ASC”) 606 — Revenue from Contracts with Customers. Under ASC 606, we recognize revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. There was no impact on our financial statements as a result of adopting Topic 606.
In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features.
When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the codification, to a scope exception.
Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all entities, including adoption in anyan interim period. We are currently assessingIf an entity early adopts the impactamendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that this standard will have on any awardsincludes that are modified once this standard is adopted.
On June 1, 2018, we adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.
This item is not applicable as we are currently considered a smaller reporting company.
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit pursuant to the requirements of the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, among other things, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Securities Exchange Act is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
Jeffrey Binder, our Chief Executive Officer and David Lamadrid,Frank Tarantino, our Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based on their evaluation, Mr. Binder and Mr. LamadridTarantino concluded that our disclosure controls and procedures are not effective in timely alerting them to material information relating to us that is required to be included in our periodic SEC filings and ensuring that information required to be disclosed by us in the reports we file or submit under the Act is accumulated and communicated to our management, including our chief executivefinancial officer, and our chief financial officer,or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure, for the following reasons:
● We do not have an independent board of directors or audit committee or adequate segregation of duties;
● We have not established a formal written policy for the approval, identification and
● We do not have an independent body to oversee our internal controls over financial reporting and lack segregation of duties due to our limited resources.
We plan to rectify these weaknesses by implementing an independent board of directors and hiring additional accounting personnel once we have additional resources to do so.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal controls over financial reporting that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
We know of no material pending legal proceedings to which the Company is a party or of which any of its property is the subject. In addition, we do not know of any such proceedings contemplated by any governmental authorities.
This item is not applicable as we are currently considered a smaller reporting company.
All sales of unregistered securities during the Company effected closings of its private securities offering conducted by WestPark Capital, Inc., as placement agent, whereby it sold an aggregate of $1,268,750 in units to a total of 15 investors in a private offering exempt from registration under Rule 506(c) of Regulation D, promulgated under the Securities Act of 1933, as amended. Each unit consisted of four shares of the Company’s common stock and one warrant to purchase one share of common stock for $0.75. The price per unit was $1.25. The net proceeds to the Company, after deducting the placement agent’s commissions, the non-accountable expense allowance and actual expenses, was $1,081,528. The offering was exempt pursuant to Rule 506(c) because it was a private offering in which only verified accredited investorsreporting period were permitted to purchase units.
None.
None.
None.
31.1 | |
31.2 | |
32.1 | |
32.2 | |
101.INS | XBRL Instance Document |
101.SCH | XBRL Taxonomy Extension Schema |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase |
101.DEF | XBRL Taxonomy Extension Definition Linkbase |
101.LAB | XBRL Taxonomy Extension Label Linkbase |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CLS HOLDINGS USA, INC. | |||
Date: | By: | /s/ Jeffrey I. Binder | |
Jeffrey I. Binder | |||
Chairman and Chief Executive Officer (Principal Executive Officer) | |||
Date: | By: | /s/ | |
Frank Tarantino | |||
Chief Financial Officer | |||
(Principal Financial and Accounting Officer) |